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CADENZA: A Jockey Club Initiative for Seniors
CADENZA:	A	Jockey	Club	Initiative	for	Seniors	is	a	HK$	380	million	project	initiated	and	funded	by	The	
Hong	Kong	Jockey	Club	Charities	Trust	in	light	of	a	rapidly	ageing	population.	The	Faculty	of	Social	Sciences	
of	The	University	of	Hong	Kong	and	the	Faculty	of	Medicine	of	The	Chinese	University	of	Hong	Kong	are	the	
project	partners.	CADENZA	aims	at	creating	an	elder-friendly	community	which	fosters	positive	community	
attitudes	towards	older	people	and	continually	improves	the	quality	of	care	and	quality	of	life	for	Hong	
Kong’s	elderly.
CADENZA	is	an	acronym	for	"Celebrate	their	Accomplishments;	Discover	their	Effervescence	and	Never-
ending	Zest	as	they	Age."	In	classical	music,	a	'Cadenza'	is	an	extended	virtuosic	section,	usually	near	the	
end	of	a	movement	in	a	concerto.	The	word	is	used	figuratively	to	describe	the	apex	of	one's	life	and	the	
celebration	of	a	lifetime's	accomplishments.	
CADENZA	has	4	main	components:
1.	 Community Projects	are	innovative	and	sustainable	service	models	designed	to	cope	with	the	changing	
needs	of	seniors.	One	of	the	innovative	projects	is	the	establishment	of	The	Jockey	Club	CADENZA	Hub	
in	Tai	Po,	which	is	an	integrated	primary	health	and	social	care	centre	for	the	old	and	the	soon-to-be-old.	
2.	 Leadership Training and Research	is	to	nurture	academic	leadership	in	gerontology,	and	to	conduct	
research	to	advance	gerontological	knowledge	and	to	evaluate	the	outcomes	of	different	CADENZA	
projects.
3.	 Public Awareness and Public Education Programmes	promote	positive	ageing	and	highlight	important	
issues	pertaining	to	the	elderly	population,	covering	6	themes:	(i)	health	promotion	and	maintenance,	(ii)	
health	and	social	services	in	Hong	Kong,	(iii)	living	environment,	(iv)	financial	and	legal	issues,	(v)	quality	
of	life	and	quality	of	dying,	and	(vi)	age	disparities.
4.	 Training Programme	includes	on-line	courses,	workshops	and	public	seminars	to	train	different	levels	of	
professional	front-line	workers,	care	givers	and	the	general	public.
The	findings	covered	by	this	report	are	part	of	the	series	"Challenges	of	population	ageing	on	disease	
trends	and	burden"	carried	out	by	CADENZA	in	collaboration	with	the	Department	of	Community	Medicine,	
the	School	of	Public	Health	of	The	University	of	Hong	Kong.		This	series	utilises	existing	data	to	estimate	the	
effect	of	the	ageing	population	on	the	impact	of	various	chronic	diseases	on	individuals	and	society	as	a	
whole.	The	current	volume	of	the	series	focuses	on	dementia.	This	report	is	made	available	to	the	public	with	
the	compliments	of	The	Hong	Kong	Jockey	Club	Charities	Trust.
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Preface
With	the	prevalence	of	ageing	populations	all	over	the	world,	the	increase	in	the	numbers	of	
people	with	dementia	has	been	described	as	a	'tidal	wave	on	the	horizon'	(Sabat,	2009),	in	that	it	
is	a	chronic	disease	that	is	one	of	the	major	contributors	to	disability	and	increases	the	burden	to	
caregivers	as	well	as	health	and	social	care	systems.	The	Hong	Kong	population	is	ageing	rapidly,	
such	that	the	population	aged	65	and	above	nearly	doubled	during	the	past	two	decades.	It	is	
projected	that	in	2036,	there	will	be	2.3	million	older	people	in	Hong	Kong	(Census	and	Statistics	
Department	of	Hong	Kong	Special	Administrative	Region,	2007b,	2009a).	Although	it	is	known	
that	dementia	becomes	more	prevalent	with	increasing	age,	a	more	accurate	assessment	of	the	
impact	of	the	disease	can	be	attempted	by	examining	the	trends	in	incidence	and	mortality	over	
a	number	of	years,	in	addition	to	simple	consideration	of	the	age-related	prevalence.	This	report	
reviews	the	trends	in	dementia	prevalence,	incidence	and	mortality	over	ten	years	in	Hong	
Kong,	including	a	comparison	with	other	developed	countries	and	estimation	of	direct	and	
indirect	costs.	The	consequence	of	increasing	numbers	of	people	with	dementia	in	Hong	Kong	is	
discussed	from	society’s,	caregivers’	and	patients’	point	of	view.	The	need	for	the	formulation	of	a	
dementia	strategy	for	Hong	Kong	is	examined	consequent	to	the	estimation	of	the	magnitude	of	
the	problem.
Preface

Executive Summary
10 Executive Summary
Dementia	is	an	age-related	condition,	with	a	prevalence	rate	that	nearly	doubles	for	every	five	years	
after	the	age	of	65.	In	Hong	Kong,	the	number	of	people	aged	65	and	above	is	rapidly	increasing	and	it	is	
projected	that	there	will	be	2.3	million	people	aged	65	and	above	in	2036.	Hence,	the	prevalence	of	dementia	
is	expected	to	increase	very	significantly,	and	the	consequent	increased	disability	burden	and	costs	of	long	
term	health	and	social	care	will	be	substantial.	The	demand	for	informal	caregivers	is	heavy.	However,	due	
to	population	ageing,	the	oldest	old	support	ratio	(population	aged	50-74:	population	aged	85+)	has	been	
decreasing	as	evidenced	in	the	past	two	decades.	The	decreasing	ratio	implies	each	informal	caregiver	is	
caring	for	more	oldest	old	people.	At	the	same	time,	even	if	there	is	no	increasing	trend	in	the	age-specific	
prevalence	rate	of	dementia,	the	number	of	older	people	who	have	dementia	can	be	expected	to	increase	
over	the	years	due	to	ageing	demographic	changes.	Given	the	shrinking	pool	of	informal	caregivers	and	
the	expanding	population	with	dementia,	a	question	of	how	to	maintain	continual	care	for	people	with	
dementia	arises.	This	report	reviews	the	trends	in	dementia	prevalence,	incidence	and	mortality	over	ten	
years	in	Hong	Kong,	including	a	comparison	with	other	developed	countries	and	an	estimation	of	burden	of	
the	disease	as	well	as	the	current	and	
future	economic	costs.	It	also	identifies	
constraints	and	suggests	ways	 to	
improve	dementia	services.
Executive Summary
Dementia	is	an	age-related	condition.	Given	the	shrinking	
pool	of	informal	caregivers	and	the	expanding	population	
with	dementia,	maintaining	continual	care	for	people	with	
dementia	is	an	important	issue	to	be	tackled.
Prevalence
Based	on	clinical	diagnoses,	two	prevalence	studies	showed	an	increasing	trend	in	dementia	prevalence	
from	1995	to	2005-2006.	In	1995,	about	4.5%	of	people	aged	70	and	above	in	the	community	had	dementia.	
The	prevalence	rates	of	dementia	increased	with	age	and	approximately	doubled	for	every	five	years	until	
around	age	90.	In	2005-2006,	the	prevalence	rate	of	dementia	among	people	aged	70	and	above	in	the	
community	was	9.3%.	About	1	in	3	(32.1%)	of	the	community-dwelling	population	aged	85	and	above	had	
dementia.	Based	on	the	prevalence	rates	of	clinically	diagnosed	dementia	in	2005-2006,	the	number	of	
cases	for	community-dwelling	people	aged	60	
and	above	is	estimated	to	increase	from	0.09	
million	in	2010	to	0.23	million	in	2036.
The	number	of	community-dwelling	people	with	
dementia	aged	60	and	above	is	estimated	to	increase	
from	0.09	million	in	2010	to	0.23	million	in	2036.
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The	prevalence	of	dementia	in	institutional	care	is	also	substantial.	 	A	study	of	the	prevalence	of	
dementia	found	that	the	prevalence	rate	of	clinically	diagnosed	dementia	among	people	aged	70	and	
above	living	in	institutions	was	17.4%	in	1995.	A	recent	survey	found	that	the	prevalence	rate	of	self-reported	
dementia	among	people	aged	60	and	above	living	in	
institutions	was	30.7%	in	2008.	Hence,	the	number	
of	people	with	dementia	aged	60	and	above	living	in	
institutions	is	estimated	to	increase	from	0.02	million	
in	2010	to	0.05	million	in	2036.
The	prevalence	rates	of	clinically	diagnosed	dementia	in	Hong	Kong	were	comparable	with	studies	in	
Japan,	but	were	higher	than	those	reported	in	China	and	Singapore	and	lower	than	those	reported	in	the	
United	States.	Discrepancy	between	studies	may	be	due	to	the	difference	in	age	structure,	the	number	of	
subjects	living	in	institutions,	vascular	risk	profile,	and	diagnostic	criteria	of	dementia.
Incidence
There	is	not	a	great	deal	of	information	on	the	local	trend	in	incidence	of	dementia.	Based	on	self-
reported	doctor	diagnosed	dementia,	a	cohort	study	in	1991-1992	found	7.9	per	1,000	subjects	aged	70	and	
above	reported	dementia	in	a	36-month	follow-up	period	(2.8	per	1,000	person-years).	There	was	no	obvious	
difference	in	the	incidence	rates	between	males	and	females	aged	less	than	80,	but	females	aged	80	and	
above	tended	to	have	a	higher	incidence	rate	of	dementia	(18.3	
per	1,000)	than	their	male	counterparts	(6.2	per	1,000).	These	
data,	however,	need	to	be	interpreted	with	caution	because	self-
reported	data	may	undercount	those	in	whom	dementia	has	
not	been	diagnosed	and	thus	leading	to	an	underestimation	of	
the	incidence	of	dementia.
The	number	of	people	aged	60	and	above	
who	have	dementia	and	live	in	institutions	is	
estimated	to	increase	from	0.02	million	in	2010	
to	0.05	million	in	2036.
From	a	 1991-1992	 cohort,	 the	
annual	incidence	rate	of	dementia	
among	the	population	aged	70	and	
above	in	Hong	Kong	was	about	2.8	
per	1,000	person-years.
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About	286,000	years	of	healthy	life	(Disability-Adjusted	Life	Years,	DALYs)	were	lost	due	to	dementia	
among	population	aged	60	and	above	in	Hong	Kong	in	2006.
Mortality 
Dementia	is	the	tenth	most	common	cause	of	mortality,	approximately	300	people	died	from	dementia	
in	2007,	accounting	for	0.8%	of	all	deaths	in	Hong	Kong.	Although	the	age-standardised	mortality	rate	from	
dementia	among	people	aged	60	and	above	remained	stable	between	2003	(30.5	per	100,000)	and	2007	
(29.0	per	100,000),	the	number	of	deaths	from	dementia	increased	gradually	among	those	aged	60	and	
above	during	the	same	period,	probably	driven	by	an	ageing	population.	Standardised	to	the	WHO	standard	
population,	the	age-standardised	mortality	rate	for	dementia	
in	Hong	Kong	was	lower	than	the	United	States,	the	United	
Kingdom,	Australia,	and	China,	but	higher	than	Singapore	
and	Japan.
Disability burden
Dementia	is	associated	with	significant	functional	disability	among	older	people	and	thereby	placing	a	
large	burden	on	patients,	caregivers	and	society.	The	burden	of	disease	from	dementia	is	calculated	from	the	
prevalence	of	dementia,	deaths	from	dementia	and	global	disability	weights.	In	2006,	about	286,000	years	of	
healthy	life	(Disability-Adjusted	Life	Years,	DALYs)	were	lost	due	to	dementia	among	the	population	aged	60	
and	above	in	Hong	Kong.	The	majority	of	the	burden	was	due	to	disability,	with	about	284,000	Years	Lost	due	
to	Disability	(YLDs)	making	up	99.3%	of	DALYs.	The	remaining	0.7%	of	the	burden	was	due	to	the	estimated	
premature	mortality,	2,000	Years	of	Life	Lost	(YLLs)	from	dementia.
Economic burden
In	addition	to	the	disability	burden,	the	economic	burden	on	the	health	care	and	social	services	systems	
is	also	substantial.	We	examined	the	direct	costs	and	indirect	costs	of	caring	for	dementia	patients	in	2010	
and	2036.	Examples	of	direct	costs	include	costs	of	hospitalisation	and	institutional	care,	while	costs	of	
Dementia	is	the	tenth	most	common	
cause	of	mortality,	accounting	for	0.8%	
of	all	deaths	in	Hong	Kong	in	2007.
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informal	care	are	examples	of	indirect	costs.	Institutional	care	and	informal	care	are	the	major	components	
for	the	costs	of	dementia.	In	2010,	the	cost	of	institutional	care	among	people	aged	60	and	above	with	
dementia	was	estimated	at	around	HK$	1,624	million,	based	on	a	prevalence	estimate	of	105,069	people	with	
dementia	in	Hong	Kong	in	2010.	By	2036,	the	cost	of	institutional	care	would	increase	by	1.6	times	to	around	
HK$	4,212	million	per	year.	Costs	of	informal	care	are	also	
projected	to	increase	as	the	prevalence	of	dementia	grows.	
The	cost	of	informal	care	was	estimated	to	be	around	HK$	
10,368	million	in	2010	and	would	increase	to	over	HK$	27,000	
million	by	2036.	These	estimates	only	include	part	of	the	costs	
involved	in	caring	for	dementia	patients.
Conclusions and recommendations
Because	of	the	increasing	number	of	people	suffering	from	dementia,	the	high	disability	burden	of	
dementia	and	costs	of	caring	for	dementia	patients	have	an	enormous	impact	on	the	health	care	and	social	
services	systems.	Therefore	the	formulation	of	a	dementia	care	strategy	as	part	of	a	care	of	the	elderly	strategy	
would	be	important	for	Hong	Kong,	in	view	of	the	magnitude	of	the	dementia	burden.	Four	elements	of	the	
strategy	are:	
• Education	and	training	to	both	the	lay	public	and	health	care	and	social	professionals.
• Comprehensive	care	and	support	for	dementia	patients	and	their	caregivers.
• Co-payment	service	as	an	alternative	mode	of	delivery.
• Increase	in	dementia	research.
In	view	of	the	magnitude	of	the	dementia	burden,	the	formulation	of	a	dementia	care	strategy	as	part	
of	a	care	of	the	elderly	strategy	would	be	important	for	Hong	Kong.
The	costs	of	 institutional	care	and	
informal	 care	 among	dementia	
patients	 aged	60	and	above	are	
estimated	to	be	around	HK$	1,624	
million	and	HK$	10,368	million	 in	
2010,	respectively.
1 Executive Summary
Introduction
Chapter 1
1 Chapter  1
1.1 Overview
Dementia	is	referred	to	as	a	group	of	progressive	diseases	of	the	brain.	These	diseases	are	
characterized	by	an	irreversible	decline	in	cognitive	and	intellectual	function	such	as	memory,	
comprehension,	learning,	ability	to	think	and	calculate,	as	well	as	language	expression	and	problem	
solving.	Patients	gradually	deteriorate	with	impaired	self-care	capability,	some	also	with	mood	and	
behavioural	disorders.
In	the	early	stage	of	the	disease,	patients	tend	to	be	increasingly	forgetful,	gradually	confused	
with	time,	places	and	persons.	There	is	memory	loss	and	the	knowledge	acquired	in	the	later	stage	
of	life	is	the	first	to	be	affected.	However,	basic	capabilities,	such	as	toilet	habits	and	recognition	of	
immediate	family	members	are	preserved.	As	the	disease	progresses,	patients	may	lose	language	
capability,	cannot	recognize	family	members,	become	incontinent	and	completely	dependent	
on	others	for	daily	activities,	thereby	imposing	a	burden	to	the	family	caregivers.	With	good	
home	care,	these	patients	can	survive	up	to	15-20	years	after	the	onset	of	illness.	In	advanced	
dementia,	patients	become	stuporous	and	bedridden.	Premature	death	may	occur	due	to	aspirated	
pneumonia	or	bone	fracture	after	a	fall.	
The	most	common	cause	of	dementia	is	Alzheimer’s	disease,	accounting	for	50-70%	of	all	
dementias	worldwide.	The	second	common	cause	is	vascular	dementia	resulting	from	multiple	
minor	strokes.	This	accounts	for	30%	of	elders	with	dementia.	Lewy	bodies	dementia	comprises	
about	10%	of	dementia	cases	and	is	distinguished	by	abnormal	brain	cells	(Lewy	bodies)	which	can	
be	seen	under	a	microscope.	Fronto-temporal	dementia,	including	Pick’s	disease,	is	less	common,	
accounting	for	5%	of	all	dementia	cases.	These	have	in	common	the	degeneration	of	the	frontal	
and	temporal	lobes.	Other	causes	can	be	due	to	brain	tumors,	severe	brain	trauma,	brain	infection,	
vitamin	B12	deficiency,	drug	and	alcohol	abuse	and	severe	thyroid	deficiency.
Alzheimer’s	disease	has	been	called	primary	degenerative	dementia.	 It	 is	referred	to	as	
'degenerative'	because	the	brain	cells	wither	away	and	die.	This	disrupts	the	production	and	
distribution	of	certain	chemicals	called	neurotransmitters	that	carry	messages	within	the	brain.	The	
disease	is	rare	among	people	at	40-50	years	of	age.	It	increases	at	60-65	years,	reaching	a	peak	at	80	
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years	and	above.	Alzheimer’s	disease	has	been	found	to	be	prevalent	in	people	with	apolipoprotein	
E	type	4	allele	gene.	However,	inheriting	this	gene	does	not	always	result	in	Alzheimer’s	disease	
(Corder	et al.,	1993).	Researchers	in	India	believe	some	external	factors	are	involved	in	interacting	
with	the	gene	to	cause	Alzheimer’s	disease.	Increasingly,	reports	suggest	that	the	use	of	antioxidants	
such	as	vitamin	E,	vitamin	B	and	lipid–lowering	agents	have	been	associated	with	a	reduction	of	
the	risk	of	Alzheimer’s	disease	(World	Health	Organization	(WHO),	2006).	At	this	stage,	the	external	
factors	that	precipitate	Alzheimer’s	disease	remain	to	be	proven.
Vascular	dementia	is	a	degenerative	cerebrovascular	disease	that	leads	to	a	progressive	decline	
in	memory	and	cognitive	functioning.	It	occurs	when	the	blood	supply	carrying	oxygen	and	
nutrients	to	the	brain	is	interrupted	by	a	blocked	or	diseased	vascular	system.	Vascular	dementia	
generally	affects	people	between	the	ages	of	60	and	75,	and	affects	more	men	than	women.	The	
sudden	onset	of	symptoms	may	be	a	sign	of	this	dementia.	Vascular	dementia	severely	impacts	
memory	and	cognitive	functioning.	Nevertheless,	vascular	dementia	is	preventable	by	adopting	a	
healthy	lifestyle	and	rigidly	controlling	blood	pressure	and	diabetic	condition.
Dementia	is	often	associated	with	functional	disabilities	and	behavioural	symptoms,	and	this	
often	results	in	a	heavy	burden	for	caregivers	over	several	years.	Caring	for	a	person	with	dementia	
over	long	periods	can	have	both	physical	and	psychological	impacts.	The	financial	costs	of	caring	
for	people	with	dementia,	particularly	informal	care,	are	also	substantial.	Access	to	comprehensive	
care	and	support,	training	and	respite	services	remain	key	needs	for	informal	caregivers	and	thereby	
relieving	the	burden	on	informal	caregivers	and	improving	the	quality	of	life	and	quality	of	care	for	
those	with	dementia	and	their	caregivers.
1.2 Diagnosis and severity classification
There	is	no	simple	test	to	diagnose	dementia.	The	diagnostic	process	may	involve	an	initial	
screening	and	assessment	followed	by	a	comprehensive	clinical	evaluation.	Initial	screening	and	
assessment	for	dementia	is	generally	initiated	when	a	patient	or	his/her	caregiver	expresses	concern	
about	symptoms	or	the	clinician	notices	signs	associated	with	dementia	such	as	a	progressive	
decline	in	memory	or	a	decrease	in	ability	to	perform	daily	activities.	
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A	variety	of	screening	questionnaires	exists	to	screen	cognitive	status	for	deficits	that	are	
considered	pathological.	The	most	commonly	used	is	the	Mini-Mental	State	Examination	(MMSE)	
(Folstein	et al.,	1975).	It	 is	not	diagnostic	of	dementia	but	it	evaluates	various	dimensions	of	
cognition	function	and	is	useful	for	documenting	subsequent	decline.	MMSE	scores	range	from	
0	to	30,	the	higher	the	score	the	better	cognitive	performance.	People	scoring	below	the	cut-
off	point	on	the	MMSE	should	undergo	further	clinical	evaluation	by	a	neurologist,	geriatrician,	
psychiatrist	or	other	medical	professional	to	confirm	or	reject	a	diagnosis	of	dementia.	The	Clock	
Drawing	Test	is	also	popular	because	it	can	assess	a	wide	range	of	functions	in	addition	to	memory,	
including	comprehension,	planning,	motor	programming	and	executive	control,	global	attention,	
visual	memory	and	reconstruction,	concentration	and	visuo-spatial	representation	(Sunderland	et 
al.,	1989).	The	Psychogeriatric	Assessment	Scales	(PAS)	provide	an	assessment	of	both	dementia	
and	depression	(Jorm	et al.,	1995).	The	Alzheimer’s	Disease	Assessment	Scale	(ADAS)	–	Cognitive	
and	Non-Cognitive	Sections	(ADAS-Cog,	ADAS-Non-Cog)	were	designed	specially	to	evaluate	all	
aspects	of	Alzheimer’s	disease	(Rosen	et al.,	1984).	There	also	exist	some	screening	tests	which	are	
administered	to	the	informant.	For	example,	the	Informant	Questionnaire	on	Cognitive	Decline	
in	the	Elderly	(IQCODE)	is	a	questionnaire	administered	to	an	informant	about	changes	in	the	
everyday	cognitive	function	of	an	elderly	person	and	aims	to	assess	cognitive	decline	independent	
of	premorbid	ability	(Jorm	and	Jacomb,	1989).
Generally,	a	comprehensive	clinical	evaluation	includes	a	clinical	interview	(covering	medical	
history	and	current	situation)	following	a	combination	of	neuropsychological,	behavioural	and	
functional	assessments.	Neuropsychological	assessment	considers	a	specific	domain	of	cognition	
such	as	comprehension,	insight	and	judgment.	Behavioural	assessment	considers	the	non-cognitive	
aspects	of	dementia	which	include	personality,	mood,	psychotic	symptoms	and	behaviours	of	
concern,	as	well	as	sleep,	eating	and	sexual	disorders.	Functional	assessment	includes	a	series	of	
simple	tasks	to	evaluate	the	patient’s	executive	functioning.	According	to	the	American	Psychiatric	
Association,	dementia	is	diagnosed	on	the	basis	of	Diagnostic	and	Statistical	Manual	of	Mental	
Disorders	(DSM)	criteria,	which	require	the	presence	of	multiple	cognitive	deficits	in	addition	to	
memory	impairment.	The	cognitive	deficits	in	the	criteria	cover	several	areas,	including aphasia	
(language	disturbance),	apraxia	(impaired	ability	to	carry	out	motor	activities	despite	intact	motor	
function),	agnosia	(failure	to	recognize	or	identify	objects	despite	intact	sensory	function),	and	
disturbance	in	executive	function	(planning,	organizing,	sequencing,	abstracting).	The	latest	version	
of	the	DSM	criteria	was	DSM-IV-TR	which	was	published	in	2000	(American	Psychiatric	Association,	
2000).
19Introduction
Once	dementia	syndrome	is	diagnosed,	the	diagnosis	of	a	subtype	is	important	because	it	
may	determine	the	possible	kind	of	treatment.	The	diagnosis	of	Alzheimer’s	disease	is	based	on	
the	criteria	of	the	National	Institute	of	Neurological	Disorders	and	Stroke-Alzheimer	Disease	and	
Related	Disorders	(NINCDS-ADRDA)	Work	Group	(McKhann	et al.,	1984).	Modifications	to	the	criteria	
have	been	proposed	recently	(Dubois	et al.,	2007).	Vascular	dementia	is	commonly	diagnosed	
according	to	the	criteria	of	the	National	Institute	of	Neurological	Disorders	and	Stroke-Association	
Internationale	pour	la	Recherche	et	I’Enseignement	en	Neurosciences	(NINDS-AIREN)	International	
Workshop	(Román	et al.,	1993).	Clinical	diagnostic	criteria	for	Lewy	body	dementia	are	reported	in	
the	third	report	of	the	dementia	with	Lewy	bodies	(DLB)	consortium	(McKeith	et al.,	2005).
Blood	tests	may	also	be	used	to	rule	out	treatable	causes	of	dementia	and	identify	signs	of	
stroke	or	other	disorders	than	can	contribute	to	dementia.	These	tests	include	a	complete	blood	
count,	glucose	levels,	thyroid-stimulating	hormone,	serum	electrolytes,	serum	creatinine,	vitamin	
B12,	and	liver	function	tests.	Structural	neuroimaging	with	either	a	computed	tomography	scan	
(CT	scan)	or	magnetic	resonance	imaging	(MRI)	in	the	initial	evaluation	is	also	used	to	confirm	or	
eliminate	other	causes	of	cognitive	impairment,	and	for	differential	diagnosis	of	dementia	(Ross	and	
Bowen,	2002;	Geldmacher,	2004;	American	Psychiatric	Association,	2007).
The	progression	of	dementia	is	normally	described	in	three	stages:	mild,	moderate	and	severe.	
The	Clinical	Dementia	Rating	(CDR)	is	one	of	the	gold	standards	of	global	rating	of	dementia.	Six	
domains	are	assessed:	memory;	orientation;	judgment	and	problem	solving;	community	affairs;	
home	and	hobbies;	and	personal	care.	CDR	ratings	are	0	for	healthy	people,	0.5	for	questionable	
dementia	and	1,	2,	3	for	mild,	moderate	and	severe	dementia	as	defined	in	the	scale	(Hughes	et 
al.,	1982).	The	Hierarchic	Dementia	Scale	(HDS)	also	provides	an	assessment	of	the	severity	of	
dementia.	It	covers	nine	major	ability	areas:	orientation,	observation,	memory,	praxis,	gnosis,	
language,	concentration,	cognition	and	motor	function,	in	six	subtests.	The	maximum	score	for	the	
whole	scale	is	200.	A	person	with	very	mild	dementia	would	score	around	160;	someone	with	very	
severe	dementia	scores	less	than	40	(Cole	et al.,	1983).	The	Global	Deterioration	Scale	(GDS)	was	also	
designed	to	classify	dementia	severity.	It	is	made	up	of	detailed	clinical	descriptions	of	seven	major	
clinically	distinguishable	stages,	ranging	from	normal	cognition	to	very	severe	dementia	(Reisberg	
et al.,	1982).
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1.3 International Classification of Disease (ICD)
The	International	Statistical	Classification	of	Disease	and	Related	Health	Problems	(ICD)	is	
published	by	the	World	Health	Organization	(WHO)	for	the	international	standard	diagnostic	
classification	of	disease.	The	ICD	is	commonly	used	to	classify	diseases	and	other	health	problems	
on	records	including	death	certificates	and	hospital	discharge	records.	According	to	the	Global	
Burden	of	Disease	(GBD)	2000	Study	(Mathers	and	Leonardi,	2003),	the	ICD	codes	for	Alzheimer’s	
disease	and	other	dementias	are:
• ICD	9th	version	(ICD-9):	290,	330,	331
• ICD	10th	version	(ICD-10):	F01,	F03,	G30,	G31
1.4 Data quoted in this report
This	report	examines	all	types	of	dementia	together,	otherwise	the	specific	type	of	dementia	is	
explicitly	stated.	In	the	survey	data	included	in	this	report,	the	definition	of	dementia	is	either	self-
reported	past	diagnosis	of	dementia	by	a	doctor	or	clinically	diagnosed	dementia	based	on	clinical	
evaluation	and	criteria.	
For	mortality	statistics,	the	ICD	is	used	for	classifying	dementia	in	Hong	Kong.	Before	2001,	
deaths	due	to	dementia	were	identified	by	ICD-9.	However,	many	deaths	due	to	dementia	were	
not	coded	accordingly	in	the	ICD-9	system	(Centre	for	Health	Protection,	Department	of	Health	of	
Hong	Kong	Special	Administrative	Region,	2005).	Hence,	this	report	reviews	only	trends	in	dementia	
mortality	in	recent	years.
As	 the	 statistics	quoted	 in	 this	 report	were	 compiled	 from	different	 sources,	 the	
conceptualization	and	compilation	methods	could	vary	considerably	across	studies.	The	
comparisons	presented	in	this	report,	therefore,	can	only	be	interpreted	in	a	broad	sense.	It	is	
recommended	that	readers	consult	the	cited	references	for	the	meta-data	of	the	studies.
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2.1 Prevalence worldwide
According	to	the	latest	GBD	report	by	the	WHO	published	in	2004,	there	were	24.2	million	
people	with	dementia	worldwide	(WHO,	2008a).	The	worldwide	prevalence	rate	of	dementia	
decreased	from	0.6%	in	2000	to	0.4%	in	2002,	whilst	between	2002	and	2004,	the	respective	figures	
remained	more	or	less	the	same	(Table	2.1)	(Mathers	et al.,	2002;	WHO,	2004b,	2008a).
Table 2.1 Worldwide prevalence of dementia, 2000-2004 
2000 2002 2004
Prevalence rate 0.% 0.% 0.%
Number of people with dementia . million 22. million 2.2 million
Data sources: Mathers et al. (2002); WHO (2004b, 2008a)
Europe	had	the	highest	dementia	prevalence	rate	(0.9%)	among	all	WHO	sub-regions,	followed	
by	the	Americas	(0.6%)	and	Western	Pacific	(0.4%)	(WHO,	2008a).
Recently,	an	international	group	of	experts	from	Alzheimer’s	Disease	International	has	
attempted	to	estimate	the	worldwide	prevalence	of	dementia	in	2010	and	2050.	They	used	United	
Nations	population	estimates	to	produce	estimates	for	all	types	of	dementia	for	five	age	bands	from	
60	to	84	years	and	for	those	aged	85	and	above.	It	was	projected	that	the	number	of	people	with	
dementia	worldwide	would	increase	from	35.6	million	in	2010	to	115.4	million	by	2050	(Alzheimer's	
Disease	International,	2009).
A	number	of	age-specific	prevalence	meta-analyses	have	also	been	done	to	examine	the	
prevalence	of	dementia.	These	studies	generally	show	similar	results	such	as	increasing	rates	with	
age.	However,	prevalence	rates	vary	markedly	from	one	study	to	another	due	to	methodological	
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differences	and	thus	making	comparisons	difficult.	Previously,	Jorm	et al.	pooled	data	from	22	
studies	(Europe,	North	America,	Australasia	and	Japan)	of	moderate	to	severe	dementia	carried	out	
between	1945	and	1985	and	estimated	that	the	prevalence	rates	increased	with	advancing	age	
and	approximately	doubled	for	every	five	years	until	around	age	95	(Jorm	et al.,	1987).	Hofman	et 
al.	pooled	data	from	12	European	studies	carried	out	between	1980	and	1990	and	gave	very	similar	
figures	(Hofman	et al.,	1991).	Lobo	et al.	pooled	data	from	11	European	studies	of	mild	to	severe	
dementia	carried	out	in	the	1990s	(the	EURODEM	study)	and	estimated	that	prevalence	rates	for	
dementia	nearly	doubled	for	every	five	years	of	age	and	that	females	had	higher	rates,	particularly	
in	the	older	age	groups	(Lobo	et al.,	2000).	The	age-specific	prevalence	rates	for	dementia	from	each	
of	these	sources	are	shown	in	Table	2.2.	
Table 2.2 Prevalence rates of dementia estimated from different studies,  
by age group, 1987-2000
Age group
Data source 65-69 70-74 75-79 80-84 85-89 90-94 95+
Jorm et al. (1987) 1.% 2.% .% 10.% 20.% .% --
Hofman et al. (1991) 1.% .1% .% 1.0% 21.% 2.2% .%
Lobo et al. (2000)
Male 1.% 2.9% .% 11.0% 12.% 22.1%*
Female 1.0% .1% .0% 12.% 20.2% 0.%*
* Figures for people aged 90 and above
2.2 Incidence worldwide
Statistics	on	the	incidence	of	dementia	are	sparse	when	compared	with	the	prevalence	statistics.	
Fratiglioni	et al.	carried	out	a	meta-analysis	of	the	age-specific	incidence	rates	of	all	dementias	based	
on	data	from	eight	European	studies	reporting	age-specific	incidence	data.	The	pooled	incidence	
rates	of	dementia	increased	dramatically	with	age	for	both	genders,	with	the	rate	among	those	
aged	65	to	69	being	2.4	per	1,000	person-years	and	among	those	aged	90	and	above	being	70.2	per	
1,000	person-years.	Females	aged	80	and	above	tended	to	have	a	higher	incidence	rate	of	dementia	
than	their	male	counterparts	(Table	2.3)	(Fratiglioni	et al.,	2000).
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Table 2.3 Incidence rates of dementia (per 1,000 person-years) from  
the meta-analysis for European studies, by age group and sex, 2000 
Age group Male Female Total
65-69 2. 2. 2.
70-74 . . .
75-79 1. 1. 1.0
80-84 2. .1 0.
85-89 . . .
90+ 0.1 1. 0.2
Data source: Fratiglioni et al. (2000)
Mathers	and	Leonardi	attempted	to	estimate	the	worldwide	incidence	rates	of	dementia	for	
the	GBD	epidemiological	regions	in	2000.	Using	the	World	Standard	Population	as	the	standard,	the	
worldwide	age-standardised	incidence	rates	of	dementia	were	estimated	to	be	88.8	per	100,000	
for	males	and	112.4	per	100,000	for	females.	Females	tended	to	have	higher	incidence	rates	of	
dementia	than	their	male	counterparts	at	all	WHO	sub-regions.	Europe	region	A	(EURO	A)	had	the	
highest	dementia	incidence	rate	(males:	97.8	per	100,000,	females:	124.8	per	100,000)	among	all	
WHO	sub-regions,	followed	by	the	Americas	region	A	(AMRO	A)	(males:	97.7	per	100,000,	females:	
122.8	per	100,000)	and	Western	Pacific	region	A	(WPRO	A)	(males:	96.8	per	100,000,	females:	120.3	
per	100,000)	(Table	2.4)	(Mathers	and	Leonardi,	2003).
Table 2.4 Estimated age-standardised* incidence rates for dementia (per 100,000), 
by WHO epidemiological sub-region, 2000
WHO sub-region Male Female
AFRO D
Algeria, Angola, Benin, Burkina Faso, Cameroon, Cape Verde, Chad, Comoros, Djibouti, Equatorial 
Guinea, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Madagascar, Mali, Mauritania, 
Mauritius, Niger, Nigeria, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, Sudan, 
Togo
.2 1.0
AFRO E
Botswana, Burundi, Central African Republic, Congo, Côte d'Ivoire, Democratic Republic of the 
Congo, Eritrea, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, South Africa, 
Swaziland, Uganda, United Republic of Tanzania, Zambia, Zimbabwe
. 9.
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WHO sub-region Male Female
AMRO A
Canada, United States of America
9. 122.
AMRO B 
Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Brazil, Chile, Colombia, Costa
Rica, Cuba, Dominica, Dominican Republic, El Salvador, Grenada, Guyana, Honduras, Jamaica, Mexico, 
Panama, Paraguay, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, 
Trinidad and Tobago, Uruguay, Venezuela
9. 11.
AMRO D
Bolivia, Ecuador, Guatemala, Haiti, Nicaragua, Peru
9. 11.
EMRO B
Bahrain, Cyprus, Iran (Islamic Republic of ), Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Oman, 
Qatar, Saudi Arabia, Syrian Arab Republic, Tunisia, United Arab Emirates
9.9 2.
EMRO D
Egypt, Iraq, Morocco, Yemen
.1 0.
EURO A
Andorra, Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, 
Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, 
Slovenia, Spain, Sweden, Switzerland, United Kingdom
9. 12.
EURO B1
Albania, Bosnia and Herzegovina, Bulgaria, Georgia, Poland, Romania, Slovakia, The former Yugoslav 
Republic of Macedonia, Turkey, Yugoslavia
9. 11.
EURO B2
Armenia, Azerbaijan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan
9.0 11.1
EURO C
Belarus, Estonia, Hungary, Kazakhstan, Latvia, Lithuania, Republic of Moldova, Russian Federation, 
Ukraine
. 11.1
SEARO B
Brunei Darussalam, Indonesia, Malaysia, Philippines, Singapore, Sri Lanka, Thailand
9. 10.9
SEARO D
Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan 
.9 1.9
WPRO A
Australia, Japan, New Zealand
9. 120.
WPRO B1
China, DPR Korea, Mongolia, Republic of Korea
9. 11.1
WPRO B2
Cambodia, Lao People's Democratic Republic, Myanmar, Vietnam
9. 112.2
WPRO B
Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia (Federated States of ), Nauru, Niue, Palau, Papua 
New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu
92.9 10.2
World . 112.
*The age-standardised incidence rates used the World Standard Population as the standard. 
Data source: Mathers and Leonardi (2003)
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2.3 Mortality worldwide
In	2004,	dementia	was	the	sixth	leading	cause	of	death	in	high-income	countries*	and	there	
were	approximately	0.5	million	people	who	died	from	dementia	worldwide	(WHO,	2008b).	The	
proportion	of	deaths	due	to	dementia	worldwide	also	increased	from	0.6%	in	2000	to	0.8%	in	
2004	(Mathers	et al.,	2002;	WHO,	2004b,	2008a).	It	was	projected	that	the	number	of	deaths	due	to	
dementia	would	increase	to	0.8	million	in	2030	(Table	2.5)	(WHO,	2008c).
Table 2.5 Worldwide number of deaths from dementia for  
years 2000-2004 and projection for 2030
2000 2002 2004 2030 % change
(2004-2030) 
Number of deaths due to dementia 0. million 0. million 0. million 0. million 1% increase
Proportion of deaths due to dementia 
among all deaths 0.% 0.% 0.% 1.2% 0% increase
Mortality rate (per 100,000) .0 . . 9. 2% increase
Data sources: Mathers et al. (2002); WHO (2004b, 2008a, 2008c)
The	worldwide	mortality	rate	for	dementia	increased	slightly	from	6.0	per	100,000	in	2000	to	
7.6	per	100,000	in	2004	(Mathers	et al.,	2002;	WHO,	2004b,	2008a).	The	mortality	rate	for	dementia	
increased	sharply	with	age	for	both	genders,	with	the	rate	among	males	aged	45	to	59	being	1.1	per	
100,000	and	among	those	aged	80	and	above	being	321.7	per	100,000	in	2004.	The	corresponding	
figures	for	females	were	0.9	per	100,000	and	414.2	per	100,000.	Females	aged	80	and	above	tended	
to	have	a	higher	mortality	rate	of	dementia	than	their	male	counterparts	(Table	2.6)	(WHO,	2008a).
* High income countries include: Andorra, Aruba, Australia, Austria, Bahamas, Bahrain, Belgium, Bermuda, Brunei 
Darussalam, Canada, Cayman Islands, Channel Islands, Cyprus, Denmark, Faeroe Islands, Finland, France, French Polynesia, 
Germany, Greece, Greenland, Guam, Iceland, Ireland, Isle of Man, Israel, Italy, Japan, Kuwait, Liechtenstein, Luxembourg, 
Malta, Monaco, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Norway, Portugal, Puerto Rico, Qatar, 
Republic of Korea, San Marino, Saudi Arabia, Singapore, Slovenia, Spain, Sweden, Switzerland, United Arab Emirates, United 
Kingdom, United States of America, United States Virgin Islands.
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Table 2.6 Worldwide mortality rates for dementia (per 100,000),  
by age group and sex, 2004
Age group Male Female
45-59 1.1 0.9
60-69 . .
70-79 . 1.0
80+ 21. 1.2
Data source: WHO (2008a)
The	Americas	had	the	highest	dementia	mortality	rate	(17.5	per	100,000)	among	all	WHO	sub-
regions	in	2004,	followed	by	Europe	(15.6	per	100,000)	and	South	East	Asia	(5.5	per	100,000)	(WHO,	
2008a).
	
2.4 Disability-Adjusted Life Years (DALYs) worldwide
According	to	the	latest	GBD	study	by	the	WHO,	dementia	caused	more	than	11	million	
Disability-Adjusted	Life	Years	(DALYs)	worldwide	in	2004	(WHO,	2008a).	It	was	projected	that	DALYs	
lost	to	dementia	would	be	nearly	20	million	in	2030	(WHO,	2008c).	Because	dementia	is	largely	a	
disease	of	older	people,	the	burden	from	dementia	is	generally	greater	in	high-income	countries,	
where	diagnosis	and	treatment	are	better	and	lead	to	increased	life-expectancy.	Dementia	was	the	
fourth	leading	cause	of	DALYs	in	high-income	countries*,	accounting	for	3.6%	of	total	DALYs	among	
all	high-income	countries	(WHO,	2008b).
Table	2.7	shows	the	variation	in	DALYs	lost	to	dementia	throughout	the	world.	Taking	into	
account	the	population	size,	Europe	had	the	highest	DALYs	per	1,000	population	(3.5	DALYs	per	1,000	
population),	followed	by	The	Americas	(2.5	DALYs	per	1,000	population)	and	Western	Pacific	(1.9	
DALYs	per	1,000	population)	(WHO,	2008a).
* High income countries include: Andorra, Aruba, Australia, Austria, Bahamas, Bahrain, Belgium, Bermuda, Brunei 
Darussalam, Canada, Cayman Islands, Channel Islands, Cyprus, Denmark, Faeroe Islands, Finland, France, French Polynesia, 
Germany, Greece, Greenland, Guam, Iceland, Ireland, Isle of Man, Israel, Italy, Japan, Kuwait, Liechtenstein, Luxembourg, 
Malta, Monaco, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Norway, Portugal, Puerto Rico, Qatar, 
Republic of Korea, San Marino, Saudi Arabia, Singapore, Slovenia, Spain, Sweden, Switzerland, United Arab Emirates, United 
Kingdom, United States of America, United States Virgin Islands.
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Table 2.7 Worldwide estimates of DALYs lost to dementia, by region, 2004
Region DALYs DALYs per 1,000 population
Africa 0. million 0.
Americas 2.2 million 2.
Eastern Mediterranean 0. million 0.
Europe .1 million .
South East Asia 1. million 1.0
Western Pacific . million 1.9
World 11.2 million 1.
Data source: WHO (2008a)
2.5 Summary
There	were	24.2	million	people	with	dementia	worldwide	in	2004.	In	2000,	the	worldwide	
age-standardised	incidence	rates	(per	100,000)	for	dementia	were	estimated	to	be	88.8	for	males	
and	112.4	for	females.	By	2030,	the	worldwide	number	of	deaths	due	to	dementia	was	projected	
to	increase	from	0.5	million	in	2004	to	0.8	million.	Dementia	caused	more	than	11	million	DALYs	
worldwide	in	2004	and	it	was	projected	that	DALYs	lost	to	dementia	would	be	nearly	20	million	in	
2030.	Among	WHO	sub-regions,	The	Americas	had	the	highest	dementia	mortality	rate	and	Europe	
had	the	highest	DALYs	lost	to	dementia	per	1,000	population	in	2004.
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Hong	Kong	has	a	rapidly	ageing	population.	The	population	aged	65	and	above	nearly	doubled	
during	the	past	two	decades,	from	0.5	million	in	1988	to	0.9	million	in	2008.	It	is	projected	that	
in	2036,	there	will	be	2.3	million	people	aged	65	and	above	in	Hong	Kong	(Census	and	Statistics	
Department	of	Hong	Kong	Special	Administrative	Region,	2007b,	2009a).	With	the	ageing	
population,	Hong	Kong	will	experience	increasingly	larger	numbers	of	older	people	with	dementia	
in	the	future.	This	chapter	reviews	the	trends	in	dementia	prevalence	and	calculates	current	
estimates	and	future	projections	of	the	number	of	people	with	dementia	in	Hong	Kong.	Prevalence	
rates	reported	in	previous	studies	in	Hong	Kong	are	also	compared	with	those	of	other	countries.
3.1 Previous estimates of dementia prevalence
A	number	of	individual	epidemiological	studies	have	investigated	the	prevalence	of	dementia	
in	older	people	in	Hong	Kong.	Prevalence	estimates	of	dementia	have	been	based	on	self-reported	
data	and	clinically	diagnosed	data.	However,	the	prevalence	of	self-reported	dementia	was	likely	
to	be	underestimated	particularly	when	symptoms	are	mild	such	that	the	respondent	is	not	fully	
aware	of	his/her	condition.	Place	of	residency	also	has	substantial	effect	on	the	prevalence	reported.	
For	these	reasons,	previous	estimates	of	dementia	prevalence	are	presented	by	diagnosis	criteria	
(self-reported	versus	clinically	diagnosed	dementia)	and	place	of	residency	(community	versus	
institutions)	in	this	report.
3.1.1 Self-reported dementia among community population
Data	were	collected	from	several	household	surveys,	which	asked	whether	the	respondent	
had	been	told	by	a	doctor	that	they	had	dementia,	had	been	diagnosed	with	dementia	in	the	past	
or	was	receiving	medical	care	for	dementia.	According	to	self-reported	estimates,	there	was	an	
increasing	trend	in	the	prevalence	rate	of	dementia	among	older	people	in	Hong	Kong	from	2000	
to	2008	(Figure	3.1)	(Census	and	Statistics	Department	of	Hong	Kong	Special	Administrative	Region,	
2001,	2005,	2009b).
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Figure 3.1 Prevalence rate of self-reported dementia among  
community-dwelling people aged 60 and above, Hong Kong, 2000-2008 
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Data sources: Census and Statistics Department of Hong Kong Special Administrative 
Region (2001, 2005, 2009b)
The	prevalence	rates	of	dementia	increased	with	age.	Based	on	the	Population	Health	Survey	
2003/2004,	the	prevalence	rate	of	dementia	was	0.8%	for	people	aged	65-69	and	5.0%	for	people	in	
the	85	and	above	age	group	(Table	3.1).	There	was	no	obvious	gender	difference	in	the	prevalence	
rates	of	dementia	(Department	of	Health	of	Hong	Kong	Special	Administrative	Region	and	
Department	of	Community	Medicine	of	the	University	of	Hong	Kong,	2005).
Table 3.1 Prevalence rates of self-reported dementia among  
community-dwelling people aged 60 and above in Hong Kong,  
by age group, 2003-2004
Age group Prevalence rate
65-69 0.%
70-74 1.%
75-79 1.%
80-84 .0%
85+ .0%
65+ 2.0%
Data source: Department of Health of Hong Kong Special Administrative Region and Department of Community Medicine of 
the University of Hong Kong (2005)
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Further	estimates	of	the	prevalence	rates	of	dementia	based	on	self-report	of	previous	doctor	
diagnoses	are	shown	in	Table	3.2.	However,	these	estimates	are	not	directly	comparable	with	the	
previous	estimates	due	to	specific	sample	selection	criteria.
Table 3.2 Further estimates of prevalence rates of self-reported  
dementia in older people in Hong Kong, 1991-1992 and 1998-1999
Year Age Sample Characteristics Prevalence rate Source
1991-1992 0+ Older people receiving allowance from the 
government and living in the community or 
in institutions
2.0% Ho et al. (199)
199-1999 + Older people living in the community who 
could walk independently or with a walking 
aid
0.% Chu et al. (200)
3.1.2 Clinically diagnosed dementia among community population
Studies	on	the	prevalence	of	clinically	diagnosed	dementia	are	scarce	in	Hong	Kong	and	
only	two	studies	have	reported	the	prevalence	rates	of	clinically	diagnosed	dementia	among	the	
community	population,	one	conducted	in	1995	(Chiu	et al.,	1998),	and	the	other	in	2005-2006	
(Elderly	Commission,	2006;	Lam	et al.,	2008).	For	the	1995	study,	elderly	aged	70	and	above	living	
in	Shatin	were	examined.	Using	DSM-IV	criteria	for	the	diagnosis	of	dementia,	the	prevalence	rate	
of	dementia	among	people	living	in	the	community	was	4.5%.	The	prevalence	rates	of	dementia	
increased	with	age	and	approximately	doubled	for	every	five	years	until	around	age	90.	For	the	
2005-2006	study,	people	aged	60	and	above	were	examined.	Using	DSM-IV	criteria	for	the	diagnosis	
of	dementia,	the	prevalence	rate	of	dementia	among	people	aged	70	and	above	was	9.3%.	Again,	
the	prevalence	rates	of	dementia	increased	with	age,	with	the	rate	among	those	aged	60	to	64	
being	1.2%	and	among	those	aged	85	and	above	being	32.1%.	
For	the	1995	study,	the	prevalence	rate	of	dementia	among	males	aged	75	to	84	was	higher	
than	that	of	females	of	the	corresponding	age	group;	but	the	reverse	was	true	for	those	aged	85	
and	above.	For	the	2005-2006	study,	the	prevalence	rate	of	dementia	among	males	aged	60	to	64	
was	higher	than	that	of	their	female	counterparts,	but	the	reverse	was	true	for	those	aged	between	
65	and	84.	While	it	is	observed	that	females	have	higher	dementia	prevalence	rates	than	males	at	
older	ages,	more	studies	are	needed	to	confirm	the	speculation.
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Table 3.3 Prevalence rates of clinical dementia among  
community-dwelling people aged 60 and above in Hong Kong,  
by age group and sex, 1995 and 2005-2006
19951 2005-20062
Age group Male Female Total Male Female Total
60-64 -- -- -- 1.9% 0.% 1.2%
65-69 -- -- -- 1.9% .2% 2.%
70-74 1.% 1.% 1.% 1.% .% .%
75-79 .% .% .1% .% 11.% 9.9%
80-84 11.1% 10.% 10.% 12.2% 2.0% 19.0%
85-89 12.0% 22.0% 1.%
.1% 2.0% 2.1%
90+ 9.% 29.9% 2.%
60+ -- -- -- .2% 9.9% .2%
70+ -- -- .1% .9% 1.% 9.%
Data sources:   1Chiu et al. (1998);   2Elderly Commission (2006) and Lam et al. (2008)
The	2005-2006	study	included	information	about	dementia	severity,	which	was	determined	
by	global	Clinical	Dementia	Rating	(CDR)	algorithms	of	1	to	3,	indicating	mild	to	severe	dementia.	
Among	the	subjects	with	clinical	dementia,	83%	had	mild	dementia,	10%	had	moderate	dementia,	
and	7%	had	severe	dementia	(Elderly	Commission,	2006;	Lam	et al.,	2008).
3.1.3 Self-reported dementia among institutional population
Because	of	the	disabling	impact	of	dementia,	a	high	proportion	of	people	with	severe	dementia	
live	in	institutions.	According	to	self-reported	estimates,	the	prevalence	rate	of	dementia	among	the	
institutional	population	aged	60	and	above	in	Hong	Kong	did	not	change	between	2004	(30.7%)	
and	2008	(30.7%)	(Census	and	Statistics	Department	of	Hong	Kong	Special	Administrative	Region,	
2005,	2009b).	In	2006,	a	prevalence	survey	among	43	institutions	for	the	elderly	showed	that	the	
self-reported	past	doctor	diagnosis	of	dementia	was	24.9%	among	those	aged	60	and	above	(Figure	
3.2)	(Chen	et al.,	2008).
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Figure 3.2 Prevalence rate of dementia among  
institutional population in Hong Kong, 2004-2008
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Data sources: Census and Statistics Department of Hong Kong Special Administrative 
Region (2005, 2009b); Chen et al. (2008)
3.1.4 Clinically diagnosed dementia among institutional population
To	our	knowledge,	only	one	study	has	reported	the	prevalence	rate	of	clinically	diagnosed	
dementia	among	people	living	in	institutions	in	the	Shatin	district	in	Hong	Kong.	According	to	Chiu	
et al.	(1998),	the	prevalence	of	clinically	diagnosed	dementia	among	the	institutional	population	
aged	70	and	above	(n=176)	was	17.4%	in	1995	(Chiu	et al.,	1998).
3.2 Current and future estimates of dementia prevalence
Age-sex-specific	prevalence	of	dementia	was	estimated	for	community	and	institutional	
populations	separately.	We	estimated	the	total	numbers	of	people	with	dementia	in	the	community	
and	in	institutions	in	Hong	Kong	by	multiplying	the	age-sex-specific	prevalence	rates	of	clinically	
diagnosed	dementia	obtained	from	the	Lam	et al.	study	(Elderly	Commission,	2006;	Lam	et al.,	
2008)	to	the	Hong	Kong	domestic	population;	and	the	self-reported	prevalence	rates	of	dementia	
obtained	from	the	Census	and	Statistics	Department	of	Hong	Kong	Special	Administrative	Region	
(2009b)	to	the	Hong	Kong	institutional	population,	respectively.	The	proportions	of	domestic	
population	and	institutional	population	in	Hong	Kong	are	assumed	to	be	constant	as	those	in	2008	
(Census	and	Statistics	Department	of	Hong	Kong	Special	Administrative	Region,	2009b).
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Assuming		the	age-sex-specific	prevalence	rates	of	dementia	among	the	community	population	
remain	unchanged,	it	was	estimated	that	0.09	million	people	aged	60	and	above	living	in	the	
community	have	dementia	in	Hong	Kong	in	2010,	of	whom	over	30%	are	aged	85	and	above.	
Using	the	same	methodology	and	assuming	that	the	age-sex-specific	prevalence	rates	among	the	
community	population	and	the	age-sex-specific	proportion	of	domestic	population	in	Hong	Kong	
remain	unchanged	until	2036,	the	number	of	people	aged	60	and	above	living	in	the	community	
with	dementia	would	be	expected	to	increase	from	0.09	million	in	2010	to	0.23	million	by	2036	(Table	
3.4).
Table 3.4 Projected numbers of people with dementia living in  
the community in Hong Kong, 2010 and 2036
2010 2036
Age group Male Female Total Male Female Total
60-74 , 10,2 1,2 11, 2,2 ,
75-84 1,2 2,0 1,02 ,1 ,1 111,
85+ 9, 1,20 2,2 1,101 , ,
60+ 1,09 ,0 ,02 9,90 1,2 22,02
Note: Individual cells may not sum to total due to rounding.
Data source: Authors’ calculations
For	the	institutional	population,	estimates	were	based	on	the	assumption	that	age-sex-specific	
prevalence	rates	of	dementia	remain	unchanged.	Self-reported	prevalence	rate	of	dementia	was	
used	instead	of	clinically	diagnosed	dementia	prevalence	rate	because	it	was	the	best	available	
age-sex-specific	dementia	prevalence	rate	among	the	institutional	population.	Assuming	constant	
rates	and	applying	these	rates	to	the	population	in	Hong	Kong	in	2010	and	2036,	around	20,000	
people	aged	60	and	above	living	in	institutions	were	estimated	to	have	dementia	in	2010.	By	2036,	
it	is	projected	that	there	will	be	around	50,000	people	aged	60	and	above	living	in	institutions	with	
dementia	(Table	3.5).	
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Table 3.5 Projected numbers of people with dementia living in  
institutional care homes in Hong Kong, 2010 and 2036 
2010 2036
Age group Male Female Total Male Female Total
60-74 1,1 90 2,2 2,90 2,2 ,
75-84 2, ,0 , ,2 11,90 1,1
85+ 1,0 , 9, ,00 19,2 2,2
60+ ,10 1,0 1, 1,1 ,00 ,1
Note: Individual cells may not sum to total due to rounding.
Data source: Authors’ calculations
Combining	the	community	and	institutional	populations,	the	projected	number	of	people	
aged	60	and	above	with	dementia	will	increase	from	0.11	million	in	2010	to	0.27	million	in	2036.	
This	corresponds	to	an	increase	of	160%.	Nevertheless,	the	above	estimates	assume	the	rates	of	
dementia	in	Hong	Kong	remain	unchanged	until	2036,	with	changing	demographic	only.	The	
prevalence	rates	do	seem	to	increase	and	the	above	projection	is	just	a	conservative	estimate.	
Hence,	the	number	of	people	with	dementia	is	expected	to	increase	even	faster.
3.3 Comparison of prevalence with other countries
A	large	number	of	surveys	of	dementia	have	been	reported	all	over	the	world.	Since	the	study	
populations	varied	in	age	structure,	the	proportion	of	subjects	living	in	institutions,	and	diagnostic	
criteria	of	dementia,	strict	comparisons	across	studies	are	not	possible.	Therefore,	international	
comparisons	can	only	be	conducted	in	a	broad	sense.	Selected	dementia	prevalence	studies	
in	Hong	Kong,	the	United	States,	the	United	Kingdom,	China,	Japan,	and	Singapore	using	DSM	
diagnostic	criteria	are	briefly	described	in	Table	3.6.	Prevalence	estimates	based	on	modelling	were	
not	included	in	the	table.
The	prevalence	rates	of	dementia	across	countries	varied	but	all	consistently	showed	a	higher	
rate	at	older	age.	Based	on	DSM	criteria,	the	prevalence	rate	of	dementia	among	people	aged	60	
and	above	in	the	study	of	Lam	et al.	(Elderly	Commission,	2006;	Lam	et al.,	2008)	in	Hong	Kong	was	
higher	than	those	reported	in	China	(Gao	et al.,	1999;	Zhou	et al.,	2006;	Llibre	Rodriguez	et al.,	2008)	
and	Singapore	(Sahadevan	et al.,	2008),	lower	than	that	reported	in	the	United	States	(Plassman	
et al.,	2007),	but	comparable	to	that	in	Japan	(Meguro	et al.,	2002).	Details	about	age-sex-specific	
prevalence	rates	of	dementia	in	individual	countries	are	presented	in	subsequent	sections.
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Table 3.6 Prevalence studies on clinically diagnosed dementia (based on DSM) in 
Hong Kong and selected countries, 1990 to present
Year Location Dementia 
diagnostic 
criteria
Sample
characteristics
Age Prevalence Alzheimer’s 
disease %
Vascular 
dementia %
Source
1995 Hong 
Kong
DSM-IV Elders living in the 
community and 
in institutions in a 
district
0+ .1% .% 29.% Chiu et al. 
(199)
2005-
2006
Hong 
Kong
DSM-IV Elders living in the 
community
0+
0+
.2%
9.%
.0%
--
20.%
--
Elderly 
Commission 
(200) 
Lam et al. 
(200)
2001-
2003
United 
States
DSM-III-R 
and DSM-IV 
Elders living in the 
community at 
baseline
1+ 1.9% 9.9% 1.% Plassman et al. 
(200)
1990 China DSM-III-R Elders living in the 
community in a 
region
0+ .2% .% 20.1% Gao et al. 
(1999)
1999-
2000
China DSM-IV Elders living in a 
rural area
0+ 2.% 0.% 11.0% Zhou et al. 
(200)
2003-
2007
China DSM-IV Elders living in 
urban and rural 
areas
+ Urban: .0%
Rural: 2.%
-- -- Llibre 
Rodriguez et 
al. (200)
1998 Japan DSM-IV Elders living in the 
community in a 
rural area
+ .% -- -- Meguro et al. 
(2002)
2001-
2003
Singapore DSM-IV Elders living in the 
community or in 
institutions
0+
+
1.%
.%
.%
--
.%
--
Sahadevan et 
al. (200)
Abbreviation: DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; DSM-IV, Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition
	
Recently,	Alzheimer’s	Disease	International	has	attempted	to	compare	the	prevalence	of	
dementia	between	Hong	Kong	and	selected	Asia-Pacific	regions	in	2005	(Access	Economics,	2006).	
Controlling	for	the	population	size,	Japan	had	the	highest	prevalence	rate	of	dementia	in	2005	(1.5%),	
followed	by	Australia	(1.0%)	and	Hong	Kong	(0.9%)	(Figure	3.3).	It	was	projected	that	the	prevalence	
of	dementia	in	Hong	Kong	would	increase	from	59,700	people	in	2005	to	332,000	people	in	2050.	
This	corresponds	to	an	increase	of	over	450%.	By	contrast,	China	started	with	a	large	number	of	
people	with	dementia	and	would	experience	an	apparently	smaller	increase	over	the	period.	The	
most	rapid	growth	in	dementia	prevalence	is	projected	for	Singapore	(8.5	times	the	number	with	
dementia	in	2050	relative	to	2005),	while	Japan	shows	the	slowest	increase	in	numbers	of	people	
with	dementia,	although	2.6	times	the	numbers	of	2005	by	2050.	The	prevalence	in	Australia	will	
approximately	triple	from	2005	to	2050	(Table	3.7)	(Access	Economics,	2006).
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Figure 3.3 Prevalence rates of dementia in selected Asia-Pacific regions, 2005 
Table 3.7 Number of people with dementia (in thousand)  
in selected Asia-Pacific regions, 2005-2050
% change
Asia-Pacific region 2005 2020 2050 (2005-2050)
Hong Kong 9. 109.2 2.0 % increase
Australia 19. 01. .1 20% increase
China (including Macao) ,1.2 9,9. 2,00. % increase
Singapore 22.0 2. 1.9 0% increase
Japan 1,1.2 ,21. ,.1 10% increase
Data source: Access Economics (2006)
3.3.1 United States
In	the	United	States,	a	population-based	study	of	non-institutionalized	individuals	was	
conducted	in	East	Boston	in	1982.	Using	DSM-III	and	NINCDS-ADRDA	criteria,	the	prevalence	rate	
of	Alzheimer’s	disease	was	estimated	to	be	10.3%	among	those	aged	65	and	above.	The	prevalence	
rates	increased	with	age,	with	the	rate	among	those	aged	65	to	74	being	3.0%	and	among	those	
aged	85	and	above	being	47.2%	(Evans	et al.,	1989).	Another	population-based	study	examining	
856	older	people	aged	71	and	above	was	conducted	in	the	United	States	in	2001-2003.	Using	DSM-
III-R	and	DSM-IV	criteria,	the	prevalence	rate	of	dementia	was	13.9%.	Again,	the	prevalence	rates	
increased	with	age,	with	the	rate	among	those	aged	71	to	79	being	5.0%	and	among	those	aged	90	
and	above	being	37.4%	(Table	3.	8)	(Plassman	et al.,	2007).
Data sources: Access Economics (2006) and authors’ calculations
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Table 3.8 Prevalence rates of clinically diagnosed dementia in the  
United States, by age group and sex, 2001-2003
Age group Male Female Total
71-79 .% .% .0%
80-89 1.% 2.% 2.2%
90+ .% .% .%
71+ 11.1% 1.% 1.9%
Data source: Plassman et al. (2007)
3.3.2 United Kingdom
In	the	United	Kingdom,	a	prevalence	study	was	conducted	in	community-dwelling	and	
institutional	populations	living	in	four	urban	areas	and	two	rural	areas.	Using	Automated	Geriatric	
Examination	Assisted	Taxonomy	(AGECAT)	organicity	and	Geriatric	Mental	State	(GMS)	criteria,	
the	prevalence	rate	of	dementia	was	estimated	to	be	6.6%	among	those	aged	65	years	and	above	
(standardised	to	the	England	and	Wales	population	1991)	(The	Medical	Research	Council	Cognitive	
Function	and	Ageing	Study,	1998).	In	2007,	the	Alzheimer’s	Society	attempted	to	estimate	the	
prevalence	of	dementia	in	the	United	Kingdom	using	previous	prevalence	figures	and	the	United	
Kingdom	population.	It	was	projected	that	the	number	of	people	with	dementia	in	the	United	
Kingdom	would	increase	from	0.7	million	in	2005	to	1.7	million	in	2051.	The	prevalence	rates	of	
dementia	would	increase	with	age	and	would	double	for	every	five	years	up	to	the	age	group	
of	85-89.	Table	3.9	shows	the	consensus	estimates	of	prevalence	rates	of	late	onset	dementia	
(Alzheimer's	Society,	2007).
Table 3.9 Consensus estimates of prevalence rates of late onset  
dementia in the United Kingdom, by age group and sex, 2005
Age group Male Female Total
65-69 1.% 1.0% 1.%
70-74 .1% 2.% 2.9%
75-79 .1% .% .9%
80-84 10.2% 1.% 12.2%
85-89 1.% 22.2% 20.%
90-94 2.% 29.% 2.%
95+ 0.0% .% 2.%
Data source: Alzheimer’s Society (2007)
0 Chapter 
3.3.3 Australia
In	Australia,	there	is	a	lack	of	epidemiological	study	of	the	age-sex-specific	prevalence	of	
dementia.	In	2009,	Alzheimer’s	Australia	commissioned	Access	Economics	to	estimate	dementia	
prevalence	rates	in	Australia	using	a	combination	of	published	epidemiological	studies	and	meta-
analyses.	It	was	projected	that	the	number	of	people	with	dementia	in	Australia	would	increase	over	
4-fold	from	approximately	0.2	million	people	in	2009	to	1.1	million	people	in	2050.	The	prevalence	
rate	of	dementia	was	low	among	people	aged	less	than	65	years	and	the	rates	doubled	for	each	
progressive	five-year	age	category	(Table	3.10)	(Access	Economics,	2009).
Table 3.10 Estimated prevalence rates of dementia in  
Australia based on modelling, by age group and sex, 2009
Age group Male Female
60-64 1.2% 0.%
65-69 1.% 1.%
70-74 .% .%
75-79 .% .%
80-84 12.1% 12.9%
85-89 21.1% 2.%
90-94 1.% .%
95+ .2% .%
Data source: Access Economics (2009)
3.3.4 China
In	China,	several	population-based	studies	on	the	prevalence	of	dementia	have	been	carried	
out.	An	early	population-based	study	examining	3,779	urban,	suburban,	and	rural	people	aged	
60	and	above	was	conducted	in	Shanghai	and	nearby	areas	in	1990.	Using	DSM-III-R	criteria,	the	
prevalence	rate	of	dementia	was	4.2%.	The	rate	increased	with	age	and	was	higher	in	women	
and	in	urban	residents	(Gao	et al.,	1999).	Another	population-based	study	examining	34,807	
community-dwelling	and	institutional	population	aged	55	and	above	was	conducted	in	Beijing,	
Xian,	Shanghai,	and	Chengdu	in	1997.	Based	on	clinical	examinations,	the	prevalence	rate	of	
dementia	(Alzheimer’s	disease	and	vascular	dementia)	among	people	aged	55	and	above	was	
2.8%	(Zhang	et al.,	2005).	Another	prevalence	study	of	people	aged	50	and	above	was	conducted	
in	Linxian,	a	rural	county,	in	1999-2000.	Using	DSM-IV	criteria	for	the	diagnosis	of	dementia,	the	
prevalence	rate	of	dementia	was	2.3%	with	Alzheimer’s	disease	being	more	common	(80.5%).	
Again,	the	prevalence	rates	increased	with	age,	with	the	rate	among	those	aged	50	to	54	being	
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0.3%	and	among	those	aged	75	and	above	being	8.2%	(Zhou	et al.,	2006).	Most	recently,	the	10/66	
Dementia	Research	Group	examined	the	prevalence	rates	of	dementia	among	people	aged	65	
and	above	in	Latin	America,	India,	and	China	in	2003-2007	based	on	a	10/66	diagnostic	dementia	
algorithm	and	DSM-IV	criteria.	In	general,	the	prevalence	rate	of	dementia	was	higher	in	urban	than	
in	rural	China.	Using	DSM-IV	criteria,	the	crude	prevalence	rate	of	dementia	in	urban	China	was	3.0%,	
whereas	that	for	rural	China	was	2.4%.	Using	the	10/66	dementia	criteria,	the	crude	prevalence	rate	
of	dementia	was	7.0%	for	urban	China	and	5.6%	for	rural	China.	The	prevalence	rates	of	dementia	
increased	exponentially	with	age	for	both	genders	(Table	3.11)	(Llibre	Rodriguez	et al.,	2008).
Table 3.11 Prevalence rates of clinically diagnosed dementia in  
urban and rural China, by age group, sex and diagnostic criteria, 2003-2007
10/66 dementia DSM-IV 
Urban Rural Urban Rural
Age group Male Female Male Female Male Female Male Female
65-69 0.0% 2.9% 1.% 1.% 0.9% 2.0% 0.1% 1.%
70-74 .% .0% .1% .2% 2.% 0.% 2.% 1.%
75-79 .0% .0% 9.1% 9.% .% 2.2% 2.% .%
80+ 1.% 2.% 19.% 1.% .% 10.1% .% 2.%
65+ (crude) .0% .% .0% 2.%
65+ (age-sex-
education-adjusted*) .0% .% .1% 2.0%
*The standardised rates used the whole 10/66 survey sample as the standard population.
Data source: Llibre Rodriguez et al. (2008)
3.3.5 Japan
In	Japan,	a	population-based	study	examining	887	community-dwelling	elderly	was	conducted	
in	Hisayama,	a	Japanese	rural	community,	in	1985.	Using	DSM-III	diagnostic	criteria	and	CT	scan,	the	
prevalence	rate	of	dementia	was	6.7%	among		residents	aged	65	and	above.	The	prevalence	rates	
increased	with	age,	with	the	rate	among	those	aged	65	to	69	being	1.8%	and	among	those	aged	
85	and	above	being	38.9%.	The	prevalence	rate	among	women	(7.5%)	was	slightly	higher	than	that	
in	men	(5.4%)	(Ueda	et al.,	1992).	Another	population-based	study	examining	1,654	people	aged	
65	and	above	was	conducted	in	Tajiri,	a	typical	agricultural	area	in	Japan,	in	1998.	Using	DSM-IV	
criteria,	the	prevalence	rate	of	dementia	was	8.5%.	Again,	the	prevalence	rates	increased	with	age	
for	both	genders	(Meguro	et al.,	2002).	Based	on	these	two	prevalence	studies,	the	prevalence	rate	
of	dementia	seemed	to	follow	an	increasing	trend	in	men	but	remained	stable	for	women	between	
1985	and	1998	(Table	3.12).
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Table 3.12 Prevalence rates of clinically diagnosed dementia in Japan,  
by age group and sex, 1985-1998
19851
(based on DSM-III criteria)
19982 
(based on DSM-IV criteria)
Age group Male Female Total Male Female Total
65-69 1.% 1.9% 1.% .% 0.9% --
70-74 .% 1.% 2.% .0% 1.9% --
75-79 1.% .0% .9% .9% 11.0% --
80-84 1.9% 1.% 1.1% 21.9% 1.% --
85+ 1.% .1% .9% .9% 9.% --
65+ .% .% .% 9.2% .0% .%
Data sources: 1Ueda et al. (1992); 2Meguro et al. (2002)
3.3.6 Singapore
In	Singapore,	the	National	Mental	Health	Survey	of	the	Elderly	conducted	in	2003	examined	
1,092	community-dwelling	elderly	aged	60	and	above.	Using	the	AGECAT	and	GMS	criteria,	it	found	
the	prevalence	rates	of	dementia	to	be	5.2%	for	those	aged	60	and	above,	6.0%	for	those	aged	65	
and	above,	and	13.9%	for	those	aged	75	and	above	(Chiam	et al.,	2004).	Another	survey	conducted	
in	2001-2003	examined	14,817	people	aged	50	and	above	living	in	the	community	or	institutions.	
Using	the	DSM-IV	criteria,	it	found	the	age-race-adjusted	prevalence	rate	of	dementia	to	be	1.3%.	
Again,	the	prevalence	rates	increased	with	age	(Table	3.13)	(Sahadevan	et al.,	2008).
Table 3.13 Prevalence rates of clinically diagnosed dementia in Singapore, 
by age group and sex, 2001-2003 
20031
(based on AGECAT and GMS)
2001-20032*
(based on DSM-IV criteria)
Age group Total Male Female Total
50-54 -- 0.1% 0.1% 0.1%
55-59 -- 0.0% 0.1% 0.1%
60-64 0.% 0.% 0.% 0.%
65-69
.0%
1.2% 1.1% 1.2%
70-74 1.% 1.9% 1.%
75-79
9.2%
.1% .2% .%
80-84 .0% .% .%
85+ 2.2% 12.% 1.% 1.%
50+§ -- 1.1% 1.% 1.%
60+ .2% -- -- --
* Rates were adjusted for race.
§ Rates were adjusted for age.
Data sources: 1Chiam et al. (2004); 2Sahadevan et al. (2008)
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3.4 Summary
Based	on	clinical	diagnoses,	two	previous	prevalence	studies	in	Hong	Kong	showed	an	
increasing	trend	in	dementia	prevalence	from	1995	to	2005-2006.	About	one	in	three	(32%)	
community-dwelling	people	aged	85	and	above	in	Hong	Kong	had	dementia	in	2005-2006.	We	
projected	that	the	number	of	community-dwelling	people	aged	60	and	above	with	dementia	
would	more	than	double	from	0.09	million	in	2010	to	0.23	million	in	2036,	of	whom	over	30%	
are	aged	85	and	above.	People	with	dementia	also	represent	a	large	proportion	of	those	living	in	
institutional	care.	A	study	of	the	prevalence	of	dementia	found	that	the	prevalence	rate	of	clinically	
diagnosed	dementia	among	people	aged	70	and	above	living	in	institutions	was	17.4%	in	1995.	We	
also	projected	that	the	number	of	people	aged	60	and	above	living	in	institutions	with	dementia	
would	increase	from	0.02	million	in	2010	to	0.05	million	in	2036.
The	prevalence	rates	of	clinically	diagnosed	dementia	reported	in	the	two	previous	prevalence	
studies	in	Hong	Kong	were	comparable	with	the	rates	in	Japan,	but	were	higher	than	those	
reported	in	China	and	Singapore	and	lower	than	those	reported	in	the	United	States.	Discrepancy	
between	studies	may	be	due	to	the	difference	in	age	structure,	the	number	of	subjects	living	in	
institutions,	vascular	risk	profile,	and	diagnostic	criteria	of	dementia.
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Cohort	studies	are	particularly	valuable	for	less-biased	investigation	of	disease	occurrence	and	
essential	for	health	care	planning.	These	studies	start	with	a	group	of	older	people	who	do	not	have	
dementia,	and	follow	them	over	time	to	measure	the	incidence	rates.	However,	there	is	a	paucity	
of	data	related	to	incidence	of	dementia	in	Hong	Kong	and	only	one	unpublished	study	has	been	
carried	out.	This	chapter	reviews	the	incidence	of	dementia	in	Hong	Kong.	Attempts	were	also	made	
to	compare	incidence	rates	in	Hong	Kong	with	those	reported	in	other	countries.
4.1 Previous estimates of dementia incidence
A	cohort	study	of	elderly	Chinese	aged	70	and	above	living	in	the	community	and	in	institutions	
was	carried	out	in	Hong	Kong	in	the	1990s	(Ho	et al.,	unpublished	data).	It	was	found	that	the	
incidence	rate	of	self-reported	doctor	diagnosis	of	dementia	was	7.9	per	1,000	in	a	36-month	follow-
up	period.	This	works	out	to	an	annual	incidence	rate	of	2.6	per	1,000	population	or	2.8	per	1,000	
person-years.	Like	the	prevalence	rates	of	dementia,	incidence	rates	increased	with	age	for	both	
genders,	with	the	rate	at	36	months	follow-up	among	those	aged	70	to	79	being	4.2	per	1,000	and	
among	those	aged	80	and	above	being	12.8	per	1,000.	There	was	no	obvious	difference	in	the	
incidence	rates	between	males	and	females	aged	less	than	80,	but	females	aged	80	and	above	
tended	to	have	a	higher	incidence	rate	of	dementia	(18.3	per	1,000)	than	their	male	counterparts	
(6.2	per	1,000)	(Table	4.1).	These	data,	however,	need	to	be	interpreted	with	caution	because	self-
reported	data	may	undercount	those	in	whom	dementia	has	not	been	diagnosed	and	thus	leading	
to	an	underestimation	of	the	incidence	of	dementia.
Table 4.1 Number and rate of self-reported dementia incidence at 36 months 
follow-up, by age group, 1991-1992
Male Female Total
Age group n* n§ % n* n§ % n* n§ %
70-79 9 2 0.  2 0. 92  0.
80+ 21 2 0. 2  1. 0 9 1.
70+ 19  0.  9 1.1 1 1 0.
* Number of subjects who were normal at baseline
§ Number of subjects impaired at 36 months follow-up
Data source: Ho et al., unpublished data
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4.2 Comparison of incidence with other countries
Comparisons	of	incidence	of	dementia	across	studies	are	difficult	due	to	differences	in	sample	
characteristics,	vascular	risk	profile,	and	diagnostic	criteria	of	dementia.	Therefore,	international	
comparisons	can	only	be	conducted	in	a	broad	sense.	There	is	scant	information	on	the	incidence	
of	dementia	in	Hong	Kong.	Results	reported	from	Ho’s	study	(Ho	et al.,	unpublished	data)	in	Hong	
Kong	and	those	from	selected	countries	including	the	United	States,	the	United	Kingdom,	China,	
and	Japan	are	briefly	described	in	Table	4.2.	Incidence	estimates	based	on	modelling	were	not	
included	in	the	table.	
The	 incidence	rates	of	dementia	across	countries	varied	but	all	consistently	show	an	
exponential	increase	of	dementia	incidence	with	age.	Hong	Kong	has	a	low	incidence	rate	of	
dementia.	This	estimate,	however,	needs	to	be	interpreted	with	caution	because	self-reported	
data	may	undercount	those	in	whom	dementia	has	not	been	diagnosed	and	thus	leading	to	an	
underestimation	of	the	incidence	of	dementia.	Compared	with	incidence	rates	of	dementia	in	other	
countries	(Kawas	et al.,	2000;	Matsui	et al.,	2009;	Meguro	et al.,	2007;	Paykel	et al.,	1994;	Waite	et 
al.,	2001),	lower	incidence	rates	have	been	reported	from	China	(Zhang	et al.,	1998).	Details	about	
age-sex-specific	incidence	rates	of	dementia	in	individual	countries	are	presented	in	subsequent	
sections.
 Table 4.2 Incidence studies of dementia in Hong Kong and selected countries
Year Location Sample
characteristics
Dementia 
diagnostic 
criteria
Age Annual incidence Source
1991-
1995
Hong 
Kong
Elders living in the community 
and  in institutions in a district
Self-reported 0+
0+
2. per 1,000 person-years
.1 per 1,000 person-years 
Ho et al., 
unpublished 
data
1985-
1998
United 
States
Elders living in the community DSM-III-R +
+
1. per 1,000 person-years
Alzheimer’s disease: 1.1 per 
1,000 person-years
Kawas et al. 
(2000)
1985-
1990
United 
Kingdom
Elders living in the community 
or in institutions
CAMDEX +  per 1,000 person-years Paykel et al. 
(199)
1991-
1994
Australia Elders living in the community 
in a city
DSM-III-R and 
DSM-IV
+ .2 per 1,000 person-years Waite et al. 
(2001)
1987-
1992
China Elders living in the community 
in a city
DSM-III + 11. per 1,000 population Zhang et al. 
(199)
1985-
2002
Japan Elders living in the community 
in a town
DSM-III-R + 2. per 1,000 person-years Matsui et al. 
(2009)
1998-
2005
Japan Elders living in the community 
in a rural area
DSM-IV and 
CDR 1+
+ 0.0 per 1,000 person-years Meguro et al. 
(200)
Abbreviation: CAMDEX, Cambridge Mental Disorders of the Elderly Examination; CDR 1+, Clinical Dementia Rating of 1 and 
above; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; DSM-IV, Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition
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Recently,	Alzheimer’s	Disease	International	has	attempted	to	compare	the	incidence	of	
dementia	among	Hong	Kong	and	selected	Asia-Pacific	regions	in	2005	(Access	Economics,	2006).	
Controlling	for	the	population	size,	Japan	had	the	highest	incidence	rate	of	dementia	in	2005	
(4.5	per	1,000	population),	followed	by	Australia	(3.0	per	1,000	population)	and	Hong	Kong	(2.7	
per	1,000	population)	(Figure	4.1).	It	was	projected	that	the	incidence	of	dementia	in	Hong	Kong	
would	increase	by	4.4	times	from	18,500	new	cases	per	year	in	2005	to	99,600	new	cases	in	2050.	By	
contrast,	China	will	experience	a	relatively	smaller	increase	over	the	period.	The	most	rapid	growth	
in	dementia	incidence	is	projected	for	Singapore	(8.3	times	the	number	of	new	cases	of	dementia	in	
2050	relative	to	2005),	while	Japan	shows	the	slowest	increase	in	incidence	of	dementia,	although	2.5	
times	the	incidence	of	2005	by	2050.	The	incidence	in	Australia	would	more	than	triple	from	2005	to	
2050	(Table	4.3)	(Access	Economics,	2006).	
Figure 4.1 Incidence rates of dementia (per 1,000 people)  
in selected Asia-Pacific regions, 2005
Data sources: Access Economics (2006) and authors’ calculations
Table 4.3 Incidence of dementia (in thousand) 
in selected Asia-Pacific regions, 2005-2050
Asia-Pacific region 2005 2020 2050 % change(2005-2050)
Hong Kong 1. 2. 99. % increase
Australia 0.2 91.1 199. 22% increase
China (including Macao) 1,21.0 2,91. ,29.0 0% increase
Singapore . 1. . % increase
Japan 0.2 9. 1,1. 19% increase
Data source: Access Economics (2006)
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4.2.1 United States
In	the	United	States,	a	13-year	follow-up	study	of	1,236	people	was	conducted	in	1985-1998	to	
estimate	age-specific	incidence	rates	of	dementia	(Kawas	et al.,	2000).	Using	DSM-III-R	criteria,	the	
annual	incidence	rate	of	dementia	(including	Alzheimer’s	disease,	mixed/multi-infarct	dementia,	
Parkinson’s	with	dementia,	other	dementia,	and	unspecified	dementia)	was	16.7	per	1,000	person-
years	among	those	aged	55	years	and	above.	The	corresponding	rate	for	Alzheimer’s	disease	
was	12.3	per	1,000	person-years.	The	incidence	rates	increased	with	age	for	both	genders.	For	
Alzheimer’s	disease,	the	incidence	rates	increased	from	0.8	per	1,000	person-years	in	the	60	to	64	
age	group	to	64.8	per	1,000	person-years	in	the	85+	age	group	(Table	4.4).	The	Framingham	Study,	
which	followed	the	subjects	for	a	maximum	of	ten	years,	also	showed	that	dementia	incidence	rates	
increased	with	age,	from	7.0	per	1,000	for	those	aged	65	to	69	to	118.0	per	1,000	for	those	aged	85	
to	89	(Bachman	et al.,	1993).
Table 4.4 Incidence rates of Alzheimer’s disease (per 1,000 person-years) in the 
United States, by age group and sex, 1985-1998
Age group Male Female Total
55-59 0.0 0.0 0.0
60-64 0.0 2. 0.
65-69 0.9 2.2 1.
70-74 . 1. .2
75-79 . 11.0 .9
80-84 12. .1 21.
85+ 2.0 2. .
55+ 11.2 1. 12.
Data source: Kawas et al. (2000)
4.2.2 United Kingdom
In	the	United	Kingdom,	a	2.4-year	follow-up	study	of	1,195	elderly	aged	75	and	above,	based	
on	the	Cambridge	Mental	Disorders	of	the	Elderly	Examination	(CAMDEX)	interview,	showed	that	
the	annual	incidence	rate	of	dementia	was	about	43	per	1,000	person-years.	The	incidence	rates	
increased	with	age	and	approximately	doubled	for	every	5	years	up	to	the	age	group	of	85-89.	The	
annual	incidence	rate	of	dementia	among	those	aged	85	to	89	(85	per	1,000	person-years)	was	
nearly	four	times	that	among	those	aged	75	to	79	(23	per	1,000	person-years)	(Paykel	et al.,	1994).
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4.2.3 Australia
In	Australia,	a	cohort	of	elderly	people	aged	75	and	above	in	Sydney	was	followed	for	an	
average	of	3.2	years.	Using	DSM-III-R	and	DSM-IV	criteria,	the	incidence	rate	of	dementia	was	54.2	
per	1,000	person-years	in	1991-1994.	The	age-specific	incidence	rates	of	dementia	increased	with	
age	for	both	genders.	Incidence	rates	were	similar	for	males	and	females	at	all	age	groups	(Table	
4.5)	(Waite	et al.,	2001).	In	2009,	Alzheimer’s	Australia	commissioned	Access	Economics	to	estimate	
dementia	incidence	in	Australia.	It	was	projected	that	the	number	of	new	cases	of	dementia	would	
increase	by	4.5	times	from	69,600	in	2009	to	385,200	in	2050	(Access	Economics,	2009).
Table 4.5 Incidence rates of dementia (per 1,000 person-years) in Australia,  
by age group and sex, 1991-1994
Age group Male Female Total
75-79 . 2. .
80-84 . . .
85-89 1.1 10. 11.
90+ -- 20.0 1.
75+ .2 1.9 .2
Data source: Waite et al. (2001)
4.2.4 China
In	China,	a	3-year	follow-up	study	examining	1,090	elderly	aged	60	and	above	using	modified	
DSM-III	criteria	was	conducted	in	an	urban	area	of	Beijing.	The	annual	incidence	rate	of	moderate	
and	severe	dementia	was	0.3%	in	1986-1989,	with	vascular	dementia	being	more	common	(Li	et 
al.,	1991).	Another	study	followed	1,970	elderly	aged	65	and	above	in	Shanghai	for	five	years.	Using	
DSM-III	criteria	for	the	diagnosis	of	dementia,	the	annual	incidence	rate	of	dementia	was	11.5	per	
1,000	population	in	1987-1992	and	Alzheimer’s	disease	accounted	for	two-thirds	of	the	cases.	The	
annual	incidence	rate	of	dementia	was	slightly	higher	in	females	(12.7	per	1,000	population)	than	
males	(9.8	per	1,000	population)	but	did	not	reach	statistical	significance	(Zhang	et al.,	1998).
4.2.5 Singapore
Information	on	incidence	of	dementia	in	Singapore	is	not	readily	available.
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4.2.6 Japan
In	Japan,	a	17-year	follow-up	study	examining	828	community-dwelling	elderly	aged	65	and	
above	was	conducted	in	the	town	of	Hisayama.	Based	on	DSM-III-R,	the	incidence	rate	of	dementia	
was	32.3	per	1,000	person-years	in	1985-2002,	with	Alzheimer’s	disease	accounting	for	45%	of	the	
new	cases	(Matsui	et al.,	2009).	Another	study	followed	539	elderly	(with	Clinical	Dementia	Rating	
(CDR)	0	or	0.5	at	baseline)	aged	65	and	above	in	Tajiri	for	five	to	seven	years.	Using	DSM-IV	and	CDR	
criteria	for	the	diagnosis	of	dementia,	the	annual	incidence	rate	of	dementia	was	40.0	per	1,000	
person-years	in	1998-2005.	The	age-specific	rates	increased	steeply	with	advancing	age	and	reached	
67.9	per	1,000	person-years	at	age	80	and	above.	The	annual	incidence	rate	of	dementia	was	higher	
in	females	aged	70	and	above	than	their	male	counterparts,	but	the	reverse	for	those	aged	65	to	69	
(Table	4.6)	(Meguro	et al.,	2007).
Table 4.6 Incidence rates of dementia (per 1,000 person-years) in Tajiri, Japan,  
by age group and sex, 1998-2005
Age group Male Female Total
65-69 1. 2. 9.
70-79 . . .9
80+ 0. 2. .9
65+ .9 .0 0.0
Data source: Meguro et al. (2007)
4.3 Summary
There	is	a	paucity	of	data	related	to	incidence	of	dementia	in	Hong	Kong.	Based	on	self-reported	
data,	a	cohort	study	in	1991-1992	found	that	there	were	about	2.6	new	cases	among	1,000	people	
aged	70	and	above	in	a	year	(2.8	per	1,000	person-years).	These	estimates,	however,	are	probably	
underestimated	and	therefore	were	not	comparable	with	other	countries.	Based	on	the	estimates	by	
Access	Economics	(2006),	the	estimated	incidence	of	dementia	from	China	and	Japan	are	generally	
higher	than	those	from	other	countries.	This	may	be	due	to	the	difference	in	age	structure,	the	
number	of	subjects	living	in	institutions,	vascular	risk	profile,	environmental	factors,	and	diagnostic	
criteria	of	dementia.	Nevertheless,	the	incidence	of	dementia	across	countries	consistently	shows	an	
exponential	increase	of	dementia	incidence	with	age.
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According	to	the	Centre	for	Health	Protection	of	Hong	Kong,	dementia	(ICD-10:	F01-F03)	has	
been	the	tenth	leading	cause	of	death	in	recent	years	(Centre	for	Health	Protection,	Department	of	
Health	of	Hong	Kong	Special	Administrative	Region,	2010).	Before	2001,	deaths	due	to	dementia	
were	identified	by	ICD-9.	However,	many	deaths	due	to	dementia	were	not	coded	accordingly	
in	the	ICD-9	system	(Centre	for	Health	Protection,	Department	of	Health	of	Hong	Kong	Special	
Administrative	Region,	2005).	Hence,	this	chapter	reviews	only	trends	in	dementia	mortality	in	
recent	years.
5.1 Mortality trends of dementia
In	Hong	Kong	there	were	a	total	of	337	deaths	in	2007	(accounting	for	0.8%	of	all	deaths)	where	
dementia	was	the	underlying	cause	(ICD-10:	F01,	F03,	G30,	G31)	(131	males,	206	females),	with	64%	
of	these	deaths	occurring	among	people	aged	85	years	and	above	(Department	of	Health	of	Hong	
Kong	Special	Administrative	Region,	2008).	Among	those	aged	60	and	above,	the	number	of	deaths	
from	dementia	has	been	increasing	gradually	since	2001	(Figure	5.1)	(Department	of	Health	of	Hong	
Kong	Special	Administrative	Region,	2008).
Figure 5.1 Number of deaths due to dementia among people  
aged 60 and above in Hong Kong, 2001-2007
0
50
100
150
200
250
300
350
2001 2002 2003 2004 2005 2006 2007
Year
N
um
be
r
of
de
at
hs
Data source: Department of Health of Hong Kong Special Administrative Region (2008)
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The	crude	mortality	rate	from	dementia	increased	slightly	from	4.1	per	100,000	in	2001	to	4.9	
per	100,000	in	2007.	However,	the	age-standardised	mortality	rate	from	dementia	increased	from	
2001	to	2002,	decreased	from	2002	to	2003	and	remained	stable	between	2003	(30.5	per	100,000)	
and	2007	(29.0	per	100,000)	among	those	aged	60	and	above	(Figure	5.2).	
Males	and	females	have	different	trends	in	dementia	mortality.	While	the	age-standardised	
mortality	rate	from	dementia	followed	a	decreasing	trend	in	women	aged	60	and	above	between	
2001	and	2007,	the	rate	for	men	decreased	from	2002	to	2003,	increased	from	2003	to	2004	and	
remained	stable	between	2004	and	2007	(Figure	5.2)	(Department	of	Health	of	Hong	Kong	Special	
Administrative	Region,	2008).	Underlying	reasons	for	the	differences	are	not	entirely	known	but	is	
thought	to	include	genetic,	environmental,	and	social	factors.	Females	had	a	higher	mortality	rate	
than	males	among	the	older	group	of	85	years	and	above.	There	also	exists	variation	in	risk	factor	
between	males	and	females.	In	addition,	more	females	are	surviving	to	advanced	ages,	and	thus	the	
rate	would	be	higher.
	
Figure 5.2 Age-adjusted* mortality rates for dementia (per 100,000) among 
people aged 60 and above in Hong Kong, by sex, 2001-2007
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* The age-adjusted mortality rates used the Hong Kong population as of mid-2007 as the standard.
Data source: Department of Health of Hong Kong Special Administrative Region (2008)
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The	mortality	rates	increased	exponentially	with	age.	In	2007,	while	males	aged	70	to	84	had	a	
higher	mortality	rate	from	dementia	than	their	female	counterparts,	the	reverse	was	observed	for	
those	aged	85	and	above	(Figure	5.3)	(Department	of	Health	of	Hong	Kong	Special	Administrative	
Region,	2008).
Figure 5.3 Age-specific mortality rates for dementia (per 100,000)  
in Hong Kong, by age group and sex, 2007
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Data source: Department of Health of Hong Kong Special Administrative Region (2008)
It	should	be	noted	that	dementia	mortality	rates	are	based	on	underlying	cause	of	death	as	
entered	on	a	death	certificate	by	a	physician,	and	many	individuals	may	have	had	competing	causes	
of	death	which	were	actually	complications	of	dementia.	Consequently,	some	misclassification	
of	reported	mortality	might	occur	in	individuals	with	competing	causes	of	death,	as	well	as	the	
possible	underreporting	of	dementia	as	the	cause	of	death.	Hence,	we	used	the	attributable	risk	
methodology	to	estimate	the	deaths	attributable	to	dementia	in	order	to	show	the	actual	burden	of	
dementia.	The	attributable	fraction	(AF)	is	the	proportion	of	cost	(e.g.	its	mortality,	disease	burden	or	
dollar	cost)	that	can	be	attributed	to	a	risk	factor	after	controlling	for	confounding	factors.	Applying	
this	to	the	population	gives	the	population	attributable	fraction	(PAF)	or	the	proportion	of	the	cost	
for	the	population	that	is	attributable	to	the	risk	factor.	The	PAF	is	estimated	as:	PAF	=	Prevalence	×	
(Relative	Risk	–	1)	/	[(Prevalence	×	(Relative	Risk	–	1))	+	1],	where	prevalence	refers	to	the	prevalence	
rate	of	dementia	in	the	population	of	interest	and	relative	risk	is	the	risk	of	someone	with	dementia	
incurring	this	cost	compared	with	someone	without	dementia.	This	PAF	is	then	applied	to	the	total	
cost	for	the	population	of	interest.
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The	relative	risk	of	all-causes	mortality	among	people	with	dementia	compared	to	those	
without	is	2.38	for	people	aged	60	to	84,	with	a	smaller	relative	risk	for	older	ages	(Mathers	and	
Leonardi,	2003).	We	estimated	that	in	Hong	Kong,	4,391	deaths	among	older	people	in	2006	could	
be	attributed	to	dementia	(that	is,	a	rate	of	400.7	per	100,000	population)	using	the	prevalence	rates	
of	dementia	estimated	in	Chapter	3.
5.2 Comparison of mortality with other countries
Based	on	the	WHO	estimates,	Figure	5.4	shows	the	trends	in	mortality	rates	of	dementia	in	Hong	
Kong	and	other	countries	from	2002	to	2004.	Standardised	to	the	WHO	standard	population,	it	was	
found	that	the	age-adjusted	mortality	rate	for	dementia	in	Hong	Kong	was	lower	than	the	United	
States,	the	United	Kingdom,	Australia,	and	China,	but	higher	than	Singapore	and	Japan	(WHO,	
2004a,	2009).	Caution	should	be	exercised	when	comparing	the	rate	across	different	countries	
because	many	people	would	have	been	recorded	as	dying	from	another	cause	which	was	itself	a	
complication	of	dementia,	and	this	can	contribute	to	the	difference	in	dementia	mortality	across	
studies.
Figure 5.4 Age-adjusted* mortality rates for dementia (per 100,000), 
by country, 2002-2004 
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* The age-adjusted mortality rates used the WHO standard population as the standard.
Data sources: Department of Health of Hong Kong Special Administrative Region (2008); WHO (2004a, 2009) 
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5.2.1 United States
In	the	United	States,	the	age-standardised	mortality	rate	for	Alzheimer's	disease	(ICD-10:	G30)	
among	people	aged	65	and	above	increased	by	37%	from	128.8	per	100,000	population	in	1999	to	
176.9	per	100,000	in	2006.	The	mortality	rates	increased	sharply	with	age.	In	2006,	the	mortality	rate	
for	Alzheimer's	disease	among	those	aged	65	to	74	was	20.2	per	100,000	while	that	among	those	
aged	85	and	above	was	848.3	per	100,000	(Table	5.1)	(National	Center	for	Health	Statistics	of	the	
United	States,	2010).
Table 5.1 Mortality rates for Alzheimer's disease# (per 100,000)  
in the United States, by age group, 1999-2006
Age group 1999 2000 2002 2004 2006
45-64 0. 0.9 0. 0.9 1.0
65-74 1. 1. 19. 19. 20.2
75-84 129. 19. 1.1 1. 1.
85+ 01. . 2. 1. .
65+ (age-adjusted*) 12. 11.2 1. 10. 1.9
# ICD-10: G30 
*The age-adjusted mortality rates used the U.S. standard population in 2000 as the standard.
Data source: National Center for Health Statistics of the United States (2010)
5.2.2 United Kingdom
In	the	United	Kingdom,	the	age-standardised	mortality	rate	for	dementia	(ICD-10:	F01,	F03,	G30,	
G31)	among	the	population	aged	60	and	above	increased	from	160.3	per	100,000	in	2001	to	177.0	
per	100,000	in	2007.	The	mortality	rates	increased	with	age	for	both	genders,	and	females	aged	
80	and	above	tended	to	have	a	substantially	higher	mortality	rate	than	their	male	counterparts.	In	
2007,	the	mortality	rates	for	dementia	were	116.4	per	100,000	and	226.3	per	100,000	for	males	and	
females,	respectively	(Table	5.2)	(Office	for	National	Statistics	of	the	United	Kingdom,	2002-2006,	
2008).
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Table 5.2 Mortality rates for dementia# (per 100,000) in England and Wales, 
by age group and sex, 2001-2007
Age 
group
2001 2003 2005 2007
Male Female Total Male Female Total Male Female Total Male Female Total
60-64 . . . . . .0 .2 .9 .0 .1 . . 
65-69 1. 11. 1. 12.0 1.2 12. 12. 11. 11.9 1.9 1.1 1.9 
70-74 0.9 . . 1. 1. 1. . . . 9.9 1.1 0. 
75-79 12.0 12. 12. 11. 10. 12.9 11.0 11. 11. 109.0 12.2 119.2 
80-84 2. 19. 0.2 21. .2 20. 2. .1 09.1 0.1 .9 9.9 
85+ . 1,0.1 1,01. .1 1,21. 1,110.2 .1 1,1. 1,022. . 1,22. 1,109.0 
60+ 10. 200. 10. 10. 21. 19.2 102.9 20. 19.9 11. 22. 1.0 
# ICD-10: F01, F03, G30, G31
Data source: Office for National Statistics of the United Kingdom (2002-2006, 2008)
5.2.3 Australia
In	Australia,	the	number	of	deaths	from	dementia	(ICD-10:	F01,	F03,	G30,	G31)	gradually	
increased	from	3,375	in	1998	to	4,773	in	2005,	and	then	sharply	increased	in	years	2006	(6,719)	and	
2007	(7,521).	The	sudden	increase	might	probably	be	due	to	an	increased	tendency	for	certifiers	to	
identify	dementia	as	a	cause	of	death	as	reflected	by	a	substantial	increase	in	the	number	of	deaths	
due	to	vascular	dementia	and	unspecified	dementia	(Australian	Bureau	of	Statistics,	2009).
Standardised	by	age,	the	mortality	rates	for	dementia	(ICD-10:	F01,	F03,	G30,	G31)	remained	
stable	between	1999	and	2003.	The	mortality	rates	from	dementia	increased	sharply	with	age	
for	both	genders,	and	females	aged	80	and	above	had	a	higher	mortality	rate	than	their	male	
counterparts.	In	2003,	the	mortality	rates	for	dementia	among	those	aged	85	and	above	were	770.2	
per	100,000	and	1,035.7	per	100,000	for	males	and	females,	respectively	(Table	5.3)	(The	Australian	
Institute	of	Health	and	Welfare,	2007).
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Table 5.3 Mortality rates for dementia# (per 100,000) in Australia, 
by age group and sex, 1999-2003
Age group
1999 2001 2003
Male Female Total Male Female Total Male Female Total
0-59 0.2 0.2 0.2 0. 0.2 0. 0.2 0. 0.
60-64 .1 .2 .2 . 2. .1 . .1 .9
65-69 1.1 11.0 12. 10. 9.2 10.0 9. 10.9 10.1
70-74 2. 0.9 . . 2. . 29.1 2.1 2.
75-79 . . 1.9 9. 0. . 9.9 . .
80-84 221.1 2.9 2.1 220. 22. 22. 22. 20. 21.9
85+ 29. 90. .9 . 9. 1. 0.2 1,0. 92.
Total (crude) 12. 2. 1. 12. 2. 19. 1. 29.9 22.2
Total 
(age-adjusted*) 1. 20. 19.9 1. 20. 19. 1. 22.2 21.1
# ICD-10: F01, F03, G30, G31
*The age-adjusted rates used the 30 June 2001 Australian population as the standard.
Data source: The Australian Institute of Health and Welfare (2007)
5.2.4 China
In	China,	mortality	rates	for	dementia	are	not	readily	available.	A	different	measure	is	presented	
here	for	reference.	It	should	be	noted	that	this	measure	is	not	comparable	to	the	others	presented	
in	this	report	as	this	measure	only	covered	dementia	patients.
Based	on	a	40-month	follow-up	study	in	Shanghai	in	2001,	the	mortality	rate	among	dementia	
patients	aged	55	and	above	in	a	40-month	period	was	6.1	per	1,000	person-years.	The	mortality	
rates	increased	with	age	for	both	genders	and	reached	120.5	per	1,000	person-years	and	115.9	per	
1,000	person-years	for	males	and	females	aged	90	and	above,	respectively	(Table	5.4)	(Hong	et al.,	
2005).
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Table 5.4 Mortality rates (per 1,000 person-years) in a 40-month period among 
dementia patients aged 55 and above in Shanghai, China, by age group and sex, 2001
Age group Male Female
55-59 0.0 0.0
60-64 0.9 0.0
65-69 0.0 0.
70-74 1.0 1.
75-79 9. .
80-84 10. 20.0
85-89 .9 .
90+ 120. 11.9
55+ . .
Data source: Hong et al. (2005)
5.2.5 Singapore
Information	on	mortality	of	dementia	in	Singapore	is	not	readily	available.
5.2.6 Japan
In	Japan,	the	mortality	rate	for	dementia	(ICD-10:	F01,	F03,	G30,	G31)	among	the	population	
aged	60	and	above	increased	from	11.6	per	100,000	in	1997	to	25.6	per	100,000	in	2008.	The	age-
specific	mortality	rates	also	increased	sharply	with	age	for	both	genders.	In	2008,	the	mortality	rate	
for	dementia	among	those	aged	60	to	64	years	was	2.3	per	100,000	while	that	among	those	aged	
85	or	above	was	166.5	per	100,000.	Males	had	higher	dementia	mortality	rates	than	their	female	
counterparts	until	the	age	of	85	(Table	5.5)	(Ministry	of	Health,	Labour	and	Welfare	of	Japan,	2010).
2 Chapter 
Table 5.5 Mortality rates for dementia# (per 100,000) in Japan, by age group, 1997-2008
Age 
group
1997 1999 2001 2003 2005 2008
Male Female Total Male Female Total Male Female Total Male Female Total Male Female Total Male Female Total
60-64 2. 1. 2.0 2. 1. 2.0 2. 1. 1.9 2. 1. 1.9 2. 1. 2.0 2.9 1.9 2. 
65-69 .1 .0 .1 .9 . . .1 2.9 . . 2. . . .1 . . . . 
70-74 . . .2 . .0 . .9 . .0 . . .9 .1 . .2 9. . .0 
75-79 10. .1 9.0 12.9 9. 11.0 1. 10.1 11. 1.9 9.9 12.0 1.9 11.0 1.1 20. 1. 1. 
80-84 2. 2.0 2. 2.9 2. 2. 1. 29.1 29.9 1.1 2.2 2.2 0.9 2.0 2. .1 . 0. 
85+ .1 9. .0 . 102. 9. 9. 11.9 109. 101. 111. 10.9 102. 12. 11.2 1.9 1. 1. 
60+ 9. 1. 11. 10. 1. 1. 12.2 1. 1. 1.1 1. 1. 1. 20. 1. 19. 0.2 2. 
5.3 Summary
Dementia	is	the	tenth	most	common	cause	of	death	in	Hong	Kong.	In	2007,	337	people	were	
recorded	as	dying	from	dementia.	Although	the	age-standardised	mortality	rate	from	dementia	
among	people	aged	60	and	above	remained	stable	between	2003	(30.5	per	100,000)	and	2007	
(29.0	per	100,000),	the	number	of	deaths	from	dementia	increased	gradually	among	those	aged	60	
and	above	during	the	same	period,	probably	driven	by	the	ageing	population.	Based	on	the	WHO	
estimation,	the	age-standardised	mortality	rate	for	dementia	in	Hong	Kong	was	lower	than	the	
United	States,	the	United	Kingdom,	Australia,	and	China,	but	higher	than	Singapore	and	Japan	in	
years	2002	and	2004.
# ICD-10: F01, F03, G30, G31
Data source: Ministry of Health, Labour and Welfare of Japan (2010)
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With	the	increase	in	life	expectancy,	disability	associated	with	dementia	has	become	a	common	
feature	in	an	ageing	society.	Disability	affects	the	health	and	quality	of	life	of	older	people	and	
is	associated	with	a	frequent	use	of	health	care	and	social	services,	thus	placing	a	large	burden	
on	patients,	caregivers	and	society.	This	chapter	reviews	the	relationship	between	dementia	and	
functional	disability	in	older	people	and	estimates	life	expectancy	at	age	60	with	and	without	
dementia,	and	the	burden	of	dementia	in	Hong	Kong	in	2010	and	2036.	
6.1 Dementia and disability
Dementia	is	a	major	contributor	to	disability.	In	a	recent	article	about	the	relationship	between	
cognitive	function	and	disability	among	older	people,	Kuo	et al.	(2007)	showed	that	cognitive	
function	was	associated	with	multiple	domains	of	disability,	including	activities	of	daily	living	(ADL),	
instrumental	activities	of	daily	living,	leisure	and	social	activities	and	lower	extremity	mobility.	
People	with	mild	cognitive	impairment	also	exhibited	higher	risk	for	loss	of	independent	ADL	
(Greiner	et al.,	1996),	and	more	gait	and	balance	impairment	(Boyle	et al.,	2007)	than	cognitively	
normal	people.	Several	prospective	studies	also	found	significant	associations	between	dementia	
and	functional	disability	as	measured	by	ADL	over	three	to	four	years	(Agüero-Torres	et al.,	1998;	
Sauvaget	et al.,	2002).	In	a	population-based	survey	of	elderly	Chinese,	ADL	dependence	was	
associated	with	dementia	and	some	other	medical	conditions	(Chen	et al.,	1995).	Occurrence	of	
hip	fractures	was	also	elevated	among	older	patients	with	dementia	(Weller	and	Schatzker,	2004).	
Plausible	explanations	for	this	association	have	been	proposed.	Cognitive	impairment	may	affect	
people’s	ability	to	perform	motor	tasks	and	consequently	reduce	muscle	strength,	resulting	in	poor	
physical	function	and	greater	risk	of	falling.	Nourhashémi	et al.	(2002)	found	that	low	cognitive	
function	was	associated	with	muscle	loss	in	a	group	of	over	7,000	community-dwelling	older	
women.	Rogers	and	Jarrot	(2008)	also	revealed	that	cognitive	status	was	a	significant	predictor	of	
handgrip	strength,	independent	of	age	and	sex.	Nevertheless,	some	studies	found	that	functional	
decline	was	the	predisposing	factor	of	the	development	of	cognitive	impairment	and	the	onset	of	
dementia	(Alfaro-Acha	et al.,	2006;	Wang	et al.,	2006).
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As	in	other	Western	countries,	the	population	in	Hong	Kong	is	ageing	rapidly	and	therefore	
the	increase	in	prevalence	of	dementia	among	the	elderly	is	concerning	because,	evidence	has	
shown	that	dementia	is	associated	with	increased	risk	of	physical	disability.	An	earlier	18-month	
follow-up	study	of	elderly	Hong	Kong	Chinese	aged	70	and	above	conducted	in	1991-1994	found	
that	dementia	was	one	of	the	main	chronic	diseases	associated	with	mild	to	severe	functional	
limitation	(as	measured	by	the	Barthel	Index)	among	the	subjects	(Woo	et al.,	1998).	Auyeung	et al.	
(2008)	found	that	poor	physical	function	and	muscle	strength	coexisted	with	cognitive	impairment,	
independent	of	muscle	mass.	Most	recently,	Tam	et al.	(2008)	found	that	even	for	older	people	
without	dementia,	decreased	cognitive	function	was	associated	with	functional	impairment.	Thus,	
the	high	prevalence	of	cognitive	impairment,	dementia,	and	functional	disability	among	older	
people	indicates	the	need	for	more	focused	attention	on	clinical	and	public	health	approaches	to	
reduce	this	disease	and	disability	burden	in	this	population.
Stigma	and	social	exclusion	associated	with	dementia	may	also	result	in	excess	disability	(Sabat,	
2009).	Previous	studies	have	shown	that	stigma	attached	to	psychiatric	disorders	may	harm	self-
esteem	(Link	et al.,	2001)	and	was	associated	with	a	lower	sense	of	psychological	well-being	and	
life	satisfaction	(Markowitz,	1998).	Stigma	associated	with	mental	illness	also	prevents	people	from	
disclosing	their	problem	and	seeking	appropriate	help	(Wahl,	1999),	thereby	delaying	recognition,	
diagnosis,	and	treatment.	Despite	its	negative	consequences,	stigma	associated	with	mental	illness	
has	received	limited	attention.	In	Hong	Kong,	a	recent	survey	shows	there	is	likely	stigma	related	
to	dementia	(Department	of	Health	of	Hong	Kong	Special	Administrative	Region,	2010).	The	level	
of	health	literacy	relating	to	dementia	was	also	low	among	the	lay	public	as	well	as	health	care	
professionals	(Chau	and	Mak	et al.,	2010;	Department	of	Health	of	Hong	Kong	Special	Administrative	
Region,	2010).	Therefore,	public	education	is	needed	to	combat	stigma	to	allow	timely	recognition	
and	diagnosis	of	dementia	for	improving	dementia	care.
6.2 Life expectancy
Using	the	Hong	Kong	Life	Tables	2006-2036	(Census	and	Statistics	Department	of	Hong	Kong	
Special	Administrative	Region,	2007a)	and	estimates	of	the	relative	risk	of	mortality	from	dementia	
from	the	GBD	study	(Mathers	and	Leonardi,	2003),	we	estimated	life	expectancy	at	age	60	in	Hong	
Kong,	with	and	without	dementia.	An	overseas	study	showed	that	the	relative	risk	of	mortality	in	
four	years	among	people	aged	55	and	above	with	dementia	compared	to	those	without	was	2.4	
(Jagger	et al.,	2000).	Despite	people	with	dementia	having	a	higher	risk	of	dying	compared	to	those	
without,	dementia	patients	in	Hong	Kong	are	expected	to	live	for	another	16	years	for	males	and	22	
years	for	females	at	the	age	of	60	(Figure	6.1-6.2,	Table	6.1).
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Figure 6.1 Survival probability for males 
with or without dementia in Hong Kong, 2006
 Figure 6.2 Survival probability for females 
with or without dementia in Hong Kong, 2006
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Table 6.1 Life Expectancy at the age of 60 (in years) between people  
with and without dementia in Hong Kong, by sex, 2006
General 
population
Population without 
dementia
Population with 
dementia Difference
Male 22 2 1 
Female 2 29 22 
Data source: Authors’ calculations
6.3 Estimation of Disability-Adjusted Life Years (DALYs)
Burden	of	disease	is	a	concept	relating	to	loss	of	life,	health	and	wellbeing.	It	can	be	quantified	
by	Disability-Adjusted	Life	Years	(DALYs)	which	combine	the	impact	of	premature	mortality	and	
morbidity.	The	premature	mortality	component	is	measured	in	terms	of	years	of	life	lost	(YLLs)	and	
the	morbidity	component	in	terms	of	years	of	life	span	living	in	states	of	less	than	full	health	(years	
lost	due	to	disability,	YLDs).	The	burden	of	dementia	in	terms	of	DALYs	has	been	studied	across	the	
world.	According	to	the	Dementia	in	Europe	Yearbook	2008,	dementia	including	Alzheimer’s	disease	
contributed	2,799,000	DALYs	(or	350	DALYs	per	100,000	population)	in	Europe	(Alzheimer	Europe,	
2008).	In	Australia,	an	estimate	of	101,762	DALYs	were	lost	due	to	dementia	in	2006,	and	the	number	
was	projected	to	increase	to	236,452	in	2031,	an	increase	of	over	130%.	DALYs	lost	due	to	dementia	
among	the	population	aged	65	and	above	made	up	over	90%	of	DALYs	lost	to	dementia	in	the	
Australian	population	(The	Australian	Institute	of	Health	and	Welfare	(AIHW),	2007).	The	following	
section	presents	the	methods	and	results	of	the	estimation	of	the	burden	of	disease	from	dementia	
in	Hong	Kong.
6.3.1 Years of Life Lost (YLLs)
YLLs	are	calculated	based	on	the	age	at	which	the	person	dies	and	the	life	expectancy	for	
people	of	that	age	(as	determined	by	a	life	table)	(Census	and	Statistics	Department	of	Hong	Kong	
Special	Administrative	Region,	2007a).	In	2006,	the	306	deaths	among	people	aged	60	and	above	
where	dementia	(ICD-10:	F01,	F03,	G30,	G31)	was	the	underlying	cause	of	death	resulted	in	almost	
2,000	YLLs	(Table	6.2).	About	58%	of	these	YLLs	were	for	females	and	82%	were	for	people	over	the	
age	of	75.
6.3.2 Years Lost due to Disability (YLDs)
YLDs	from	dementia	are	calculated	by	multiplying	the	number	of	people	with	dementia	
in	Hong	Kong	by	the	disability	weight	that	applies	to	them.	It	is	assumed	that	all	people	with	
dementia	in	2006	experienced	their	condition	for	the	entire	year.	Based	on	the	Dutch	weights	from	
 Chapter 
the	GBD	study	of	WHO	(Murray	and	Lopez,	1996;	Stouthard	et al.,	1997),	disability	weights	for	mild,	
moderate	and	severe	dementia	are	0.27,	0.63,	and	0.94,	respectively.	Because	disability	weights	for	
dementia	are	defined	for	different	levels	of	severity	of	dementia,	the	estimation	of	YLDs	required	
the	average	disability	weight	to	be	calculated.	Based	on	a	local	study	conducted	by	Chiu	et al.	(2002)	
the	proportions	of	mild,	moderate	and	severe	dementia	were	65.6%,	25.0%,	and	9.4%,	respectively.	
Therefore,	combined	with	the	disability	weights	listed	above,	the	average	disability	weight	for	
dementia	is	calculated	as	(0.656	×	0.27)	+	(0.25	×	0.63)	+	(0.094	×	0.94)	=	0.42.	The	YLDs	due	to	
dementia	is	thus	calculated	by	multiplying	the	number	of	people	with	dementia	by	the	disability	
weight	and	the	life	span	with	dementia.	This	shows	that,	overall,	there	were	about	284,000	YLDs	due	
to	dementia	for	people	aged	60	and	above	in	2006.
6.3.3 Disability-Adjusted Life Years (DALYs)
The	total	burden	of	disease	from	dementia,	measured	in	DALYs	is	the	sum	of	the	burden	from	
premature	death	(YLLs)	and	the	burden	of	disability	(YLDs).	In	total,	about	286,000	years	of	healthy	
life	were	lost	due	to	dementia	for	people	aged	60	and	above	in	Hong	Kong	in	2006.	The	majority	
of	burden	was	due	to	disability,	with	YLDs	making	up	99.3%	of	DALYs.	The	remaining	0.7%	of	the	
burden	was	due	to	the	YLLs	from	dementia	(Table	6.2).
Table 6.2 DALYs due to dementia among people  
aged 60 and above in Hong Kong, by sex, 2006
Aged 60+ Male Female Total
YLLs 9 1,1 1,9
YLDs 2,212 202,11 2,2
DALYs ,01 20,22 2,1
Note: Individual cells may not sum to total due to rounding.
Data source: Authors’ calculations
6.4 Summary
Dementia	is	the	leading	cause	of	functional	disability	in	older	people.	However,	 limited	
awareness	of	dementia	denies	its	existence	or	attaches	stigma	to	the	condition,	leading	to	excess	
disability.	The	burden	of	disability	associated	with	dementia	is	substantial.	In	2006,	about	286,000	
years	of	healthy	life	(DALYs)	were	lost	due	to	dementia	in	Hong	Kong.	The	majority	of	the	burden	
was	due	to	disability,	with	about	284,000	YLDs	making	up	99.3%	of	DALYs.	The	remaining	0.7%	of	
the	burden	was	due	to	the	estimated	premature	mortality,	2,000	YLLs	from	dementia.
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Because	of	the	increasing	number	of	persons	suffering	from	dementia,	costs	of	care	and	
nursing	of	people	with	dementia	have	an	enormous	economic	impact	on	the	health	care	and	social	
services	systems	(Leung	et al.,	2003).	The	worldwide	cost	of	dementia	was	estimated	to	be	US$	
315.4	billion	in	2005,	whereas	informal	care	constitutes	over	one-third	of	the	costs	(37%)	(Wimo	et 
al.,	2007).	In	Hong	Kong,	the	economic	burden	of	informal	care	is	particularly	substantial	because	
the	majority	of	elderly	people	living	in	the	community	receive	care	from	informal	caregivers	(Chow,	
1993).	A	telephone	survey	conducted	between	2003	and	2004	showed	that	primary	caregivers	in	
Hong	Kong	had	poorer	physical	and	mental	health	and	such	caregivers	were	the	major	sources	
of	financial	support	in	caring	for	the	elderly	(Ho	et al.,	2007;	You	et al.,	2008).	Wimo	et al.	(2007)	
estimated	that	the	direct	costs	and	informal	care	costs	in	Hong	Kong	totalled	US$	1.1	to	2.1	billion	in	
2005.	According	to	Wimo	et al.	(2007),	Hong	Kong	was	found	to	have	a	similar	amount	of	costs	per	
dementia	patient	as	Japan	and	Singapore,	but	higher	than	China	and	lower	than	the	United	States,	
the	United	Kingdom	and	Australia.	This	chapter	examines	the	direct	and	indirect	costs	of	dementia.	
Examples	of	direct	costs	include	costs	of	hospital	admissions	and	institutional	care,	while	costs	of	
informal	care	are	examples	of	indirect	costs.
7.1 Hospitalisation
According	to	the	Hospital	Authority	statistics,	there	were	3,050	inpatient	discharges	and	deaths	
(inpatient	episodes)	with	dementia	(ICD-10:	F00-F03,	G30)	as	the	principal	diagnosis,	in	both	public	
and	private	hospitals,	in	Hong	Kong	in	2006	(98%	in	public	hospitals)	(Figure	7.1)	(Hospital	Authority	
of	Hong	Kong	Special	Administrative	Region,	2003-2009).	Assuming	78%	of	these	episodes	came	
from	those	aged	60	and	above	and	the	mean	bed-day	of	these	episodes	was	25	days,	we	estimated	
the	annual	cost	of	hospitalisation	for	dementia	in	people	aged	60	and	above	by	multiplying	the	
number	of	episodes	with	the	mean	bed-day	and	the	standard	public	ward	fee	per	day.	The	standard	
public	ward	fee	(i.e.	a	cost	recovery	charge)	per	day	was	HK$	3,300	in	2006	(Special	Supplement	
No.	4	to	Gazette	No.	13/2003,	2003).	It	was	estimated	that	the	annual	cost	of	hospitalisation	for	
dementia	in	people	aged	60	and	above	was	around	HK$	197	million	(3,050	×	0.776	×	25.3	×	$3,300)	
in	Hong	Kong	in	2006.
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Figure 7.1 Number of inpatient episodes with principle diagnosis of 
dementia in Hong Kong in both public and private sectors, 2001-2007
Table 7.1 Estimated cost of hospitalisation for people aged 60 and above  
with dementia in Hong Kong, 2006
Aged 60+ 2006
Numbers of dementia inpatient episodes in both public and private hospitals ,00
Estimated numbers of these episodes that were contributed by people aged 0 and above 2,
Estimated mean bed-day of each of these episodes 2
Cost per inpatient bed-day (HK$) ,00
Estimated cost of hospitalisation (HK$ million) 197
Data source: Authors’ calculations
Using	the	same	methodology	as	in	section	3.2,	we	estimated	that	in	2006,	there	were	about	
90,806	people	aged	60	and	above	with	dementia	living	in	both	the	community	and	institutional	
care	in	Hong	Kong.	The	rate	of	hospital	utilization	among	dementia	patients	aged	60	and	above	was	
estimated	by	dividing	the	number	of	dementia	inpatient	episodes	contributed	by	people	aged	60	
and	above	by	the	estimated	number	of	people	aged	60	and	above	with	dementia	in	2006,	i.e.:	26.1	
per	1,000	(2,367/	90,806).
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In	section	3.2,	we	estimated	that	in	2010,	there	would	be	about	105,069	people	aged	60	and	
above	in	Hong	Kong	with	dementia.	Assuming	a	constant	rate	of	hospital	utilization	among	
dementia	patients	aged	60	and	above	between	2006	and	2010,	the	estimated	annual	cost	of	
dementia	inpatient	episodes	among	people	aged	60	and	above	would	be	around	HK$	228	million	
in	2010	(Table	7.2).	Using	the	same	methodology	and	assuming	that	the	rates	remain	the	same,	by	
2036,	the	annual	cost	for	hospitalisation	would	be	expected	to	more	than	double	to	HK$	594	million	
(Table	7.2).
Table 7.2 Estimated cost of hospitalisation for people aged 60 and above  
with dementia in Hong Kong, 2010 and 2036
Aged 60+ 2010 2036
Projected number of people with dementia 10,09 2,9
Estimated number of dementia inpatient episodes (Projected number of 
people with dementia × rate of hospital utilization) 2,9 ,12
Estimated mean bed-days of each of these episodes 2 2
Cost per inpatient bed-day (HK$) ,00 ,00
Estimated cost of hospitalisation per year (HK$ million) 228 594
Data source: Authors’ calculations
These	estimates,	however,	need	to	be	interpreted	with	caution	because	episodes	related	to	
complications	of	dementia,	e.g.	pneumonia,	were	not	coded	under	dementia	and	thus	leading	to	
underestimation	of	the	cost	of	hospitalisation	of	dementia.	In	addition,	the	above	estimates	were	
conservative	estimate	only.	
Hence,	we	used	the	attributable	risk	methodology	to	estimate	the	hospitalisation	costs	
attributable	to	dementia	in	order	to	show	the	actual	burden	of	dementia.	The	attributable	cost	of	
hospitalisation	was	estimated	using	(i)	the	number	of	inpatient	episodes	for	all	causes	of	admission	
in	2006	being	531,819	(Hospital	Authority	of	Hong	Kong	Special	Administrative	Region,	2008),	
(ii)	age-sex-specific	prevalence	rates	of	dementia	as	presented	in	Chapter	3,	(iii)	relative	risk	of	
hospitalisation	associated	with	dementia	being	3.68	(Bynum	et al.,	2004),	(iv)	an	average	bed-days	of	
8	days	per	stay	(not	disease	specific),	and	(v)	a	unit	cost	of	an	inpatient	bed-day	based	on	the	charge	
for	non-eligible	persons	in	Hong	Kong	being	HK$	3,300	(Special	Supplement	No.	4	to	Gazette	No.	
13/2003,	2003).	The	attributable	cost	of	hospitalisation	for	dementia	among	people	aged	60	and	
above	was	estimated	to	be	around	HK$	2.5	billion	in	2006.	It	is	estimated	that	the	attributable	cost	
of	hospitalisation	for	dementia	among	people	aged	60	and	above	would	be	around	HK$	2.9	billion	
in	2010.	By	2036,	it	would	be	expected	to	increase	to	HK$	7.6	billion.
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7.2 Institutional care	
7.2.1 Government subsidised institutional care places
In	section	3.2,	we	estimated	that	in	2010,	there	would	be	about	18,666	people	aged	60	and	
above	living	in	institutional	care	in	Hong	Kong	with	dementia.	Based	on	statistics	provided	by	the	
Social	Welfare	Department	(SWD),	about	32%	of	institutional	places	were	subsidised	by	the	Hong	
Kong	government	in	2010	(Social	Welfare	Department	of	Hong	Kong	Special	Administrative	Region,	
2010).	Therefore,	it	was	estimated	that	6,036	people	with	dementia	would	be	living	in	government	
subsidised	places	in	Hong	Kong	in	2010.	
Based	on	the	report	published	by	the	Audit	Commission	of	Hong	Kong	(2002),	the	estimated	
average	government	subsidies	for	providing	residence	services	for	the	elderly	in	2001	was	about	
HK$	97,311	per	place	per	year	(HK$	2,417.6	million	/	24,844	places).	Based	on	the	SWD	figures,	the	
average	charge	for	a	subsidised	place	each	month	paid	by	the	elderly	or	their	family	caregivers	
was	approximately	HK$	1,755	(or	HK$	21,060	per	year)	in	2010	(SWD,	2010).	Hence,	the	cost	for	a	
government	subsidised	institutional	care	place	was	taken	as	HK$	118,371	(=HK$	97,	311	+	HK$	
21,060)	per	year.
We	estimated	that	the	costs	of	government	subsidised	institutional	care	for	people	aged	60	and	
above	with	dementia	would	be	around	HK$	714	million	in	2010	(Table	7.3).	Assuming	a	constant	
percentage	of	government	subsidised	places	among	all	institutional	places	between	2010	and	
2036,	using	the	same	methodology,	by	2036,	cost	of	government	subsidised	institutional	care	for	
people	aged	60	and	above	with	dementia	would	increase	to	around	HK$	1,853	million	(Table	7.3).
Table 7.3 Estimated cost of government subsidised institutional care  
for people aged 60 and above with dementia in Hong Kong, 2010 and 2036
Aged 60+ 2010 2036
Projected number of people with dementia in institutional care 1, ,1
Proportion of government subsidised places among all institutional places 2.% 2.%
Projected number of people with dementia living in government subsidised 
places ,0 1,
Costs per place per year (HK$ million) 0.11 0.11
Estimated annual cost of government subsidised institutional care for 
dementia patients aged 60 and above (HK$ million) 714 1,853
Data source: Authors’ calculations
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7.2.2 Private institutional care places
Since	about	two-thirds	of	institutional	care	places	were	not	subsidised	by	government,	we	
estimated	that	12,631	and	32,762	people	aged	60	and	above	with	dementia	would	be	living	in	
places	not	subsidised	by	government	in	Hong	Kong	in	2010	and	2036,	respectively.	Although	places	
not	subsidised	by	government	include	private	homes	and	institutions	run	by	non-governmental	
organisations,	for	simplicity,	we	used	private	institutional	care	places	to	describe	both	categories.	
Based	on	a	survey	conducted	by	the	Consumer	Council,	the	average	charges	for	a	private	
institutional	care	place	was	around	HK$	6,000	per	month	(Consumer	Council,	2006).	We	estimated	
that	the	costs	of	private	institutional	care	for	people	aged	60	and	above	with	dementia	would	be	
around	HK$	909	million	in	2010.	Assuming	a	constant	percentage	of	private	institutional	care	places	
among	all	institutional	places	between	2010	and	2036,	using	the	same	methodology,	by	2036,	cost	
of	private	institutional	care	for	people	aged	60	and	above	with	dementia	would	increase	to	around	
HK$	2,359	million	(Table	7.4).
Table 7.4 Estimated cost of private institutional care for people  
aged 60 and above with dementia in Hong Kong, 2010 and 2036
Aged 60+ 2010 2036
Projected number of people with dementia living in private institutional care 12,1 2,2
Average charges for a place at private institutional care unit per year (HK$ 
million) 0.02 0.02
Estimated annual cost of private institutional care (HK$ million) 909 2,359
Data source: Authors’ calculations
7.2.3 Estimated total cost of institutional care
We	estimated	the	total	cost	of	institutional	care	for	patients	aged	60	and	above	with	dementia	
by	totalling	the	costs	for	government	subsidised	institutional	care	places	and	the	costs	for	private	
institutional	care	places.	It	was	estimated	that	in	2010,	the	annual	cost	of	institutional	care	in	
people	aged	60	and	above	was	around	HK$	1,624	million.	By	2036,	it	would	increase	to	around	HK$	
4,212	million.	Nevertheless,	these	estimates	have	not	taken	into	account	subsidies	from	the	non-
governmental	organisations.	
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7.3 Informal care
Most	people	with	dementia	receive	care	at	home	initially,	with	day-to-day	personal	needs	
supported	by	family	caregivers.	Therefore,	the	cost	of	informal	care	for	dementia	is	one	of	the	main	
burdens	to	society.	Costing	informal	care	and	unpaid	work	is	indeed	a	controversial	and	complicated	
issue,	and	several	methods	have	been	proposed.	Informal	care	should	be	valued	by	the	opportunity	
cost	of	the	caregivers’	time;	however,	identifying	this	opportunity	cost	is	not	straightforward.
We	estimated	the	cost	of	informal	care	by	valuing	the	alternative	paid	employments	of	the	time	
spent	on	caring.		Using	a	median	wage	from	main	employment	of	HK$	10,000	per	month	in	2006	as	
reference	(Census	and	Statistics	Department	of	Hong	Kong	Special	Administrative	Region,	2007c),	
it	was	estimated	that	the	opportunity	cost	of	this	informal	care	for	people	aged	60	and	above	
with	dementia	was	around	HK$	10,368	million	in	2010.	By	2036,	this	would	increase	to	HK$	27,004	
million.
Table 7.5 Estimated cost of informal care for people aged 60 and above  
with dementia in Hong Kong, 2010 and 2036
Aged 60+ 2010 2036
Projected number of people with dementia living in the community ,02 22,02
Median monthly income from main employment (HK$) 10,000 10,000
Estimated cost of informal care per year (HK$ million) 10,368 27,004
Data source: Authors’ calculations
7.4 Summary
Institutional	care	and	informal	care	are	the	major	components	for	costs	of	dementia.	In	2010,	
the	cost	of	institutional	care	resulting	from	dementia	in	people	aged	60	and	above	is	estimated	
at	around	HK$	1,624	million,	based	on	a	prevalence	estimate	of	105,069	people	with	dementia	in	
Hong	Kong	in	2010.	By	2036,	the	cost	of	institutional	care	would	increase	by	1.6	times	to	around	
HK$	4,212	million	per	year.	Costs	of	informal	care	are	also	projected	to	increase	as	the	prevalence	
of	dementia	grows.	Costs	of	informal	care	were	estimated	to	be	around	HK$	10,368	million	in	2010	
and	would	increase	to	HK$	27,004	million	by	2036.	These	estimates	only	include	part	of	the	costs	
involved	in	caring	for	dementia	patients.
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8.1 Awareness and stigma
There	is	a	prevalent	view	among	health	and	social	care	professionals	as	well	as	the	lay	public	
that	dementia	is	an	inevitable	normal	accompaniment	of	ageing,	instead	of	a	chronic	disease	
which	patients	ultimately	die	from.	There	is	lack	of	awareness	that	dementia	makes	the	largest	
contribution	to	disability	in	China	and	other	developing	countries	(Sousa	et al.,	2009).	In	addition,	
it	is	not	widely	appreciated	that	poor	physical	function	and	muscle	strength	often	co-exist	with	
cognitive	impairment	(Auyeung	et al.,	2008).
Furthermore	there	is	anecdotal	evidence	of	social	concealment	of	the	condition,	which	appears	
to	carry	some	degree	of	stigma,	resulting	in	social	exclusion.	Studies	in	other	countries	have	
documented	reduced	social	contact	after	diagnosis,	and	different	social	interactions	with	friends	
and	relatives	(Werner	and	Heinik,	2008).	Stigma	may	create	a	barrier	between	dementia	sufferers	
and	various	medical	and	psychosocial	interventions.	Excess	disability	can	be	created	as	a	result	of	
how	patients	are	treated	by	others	(Sabat,	2009).
Recent	surveys	of	lay	public	as	well	as	health	care	professionals	show	that	the	level	of	health	
literacy	relating	to	dementia	is	low	(Chau	and	Mak	et al.,	2010;	Department	of	Health	of	Hong	
Kong	Special	Administrative	Region,	2010).	Therefore	public	education	and	training	of	health	care	
professionals	are	both	needed	in	raising	awareness	of	the	disease	and	its	management.	In	particular	
there	is	a	need	to	educate	all	on	how	to	communicate	with	those	who	have	dementia.
8.2 Prevention and early detection
Although	few	risk	factors	have	been	identified	for	Alzheimer’s	disease,	which	accounts	for	
approximately	65%	of	dementia	in	Hong	Kong	(Chiu	et al.,	1998),	about	one-third	is	caused	by	
underlying	cardiovascular	disease	resulting	in	stroke.	There	is	evidence	that	a	'healthy	lifestyle'	
is	associated	with	a	slower	decline	in	cognitive	function	in	large-scale	prospective	studies.	A	
population-based	study	of	more	than	1,400	people	showed	that	high	age,	 low	education,	
hypertension,	hypercholesterolaemia,	and	obesity	were	associated	with	increased	risk	of	dementia	
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20	years	later	(Kivipelto	et al.,	2006).	Therefore	there	is	room	for	prevention	or	reduction	of	vascular	
dementia	by	modifying	lifestyle:	avoidance	of	smoking,	alcohol	in	moderation,	a	diet	rich	in	fruits,	
vegetables	and	fish	but	low	in	saturated	fats,	maintenance	of	optimal	body	weight,	and	regular	
physical	activity.	Detection	and	effective	treatment	of	hypertension	are	also	important.	A	scoring	
system	for	the	prediction	of	the	risk	of	late-life	dementia	in	people	of	middle	age	on	the	basis	of	
their	risk	profiles	has	been	developed	(Kivipelto	et al.,	2006).	It	has	been	estimated	that	delaying	the	
onset	of	dementia	by	two	years	could	lead	to	a	20%	reduction	in	Alzheimer’s	disease	prevalence	
while	a	5-year	delay	could	result	in	a	50%	reduction	(Brookmeyer	et al.,	1998).
Currently	diagnosis	tends	to	be	made	at	a	later	stage	of	the	disease,	with	up	to	90%	of	people	
with	mild	dementia	being	undetected	in	the	primary	care	setting.	Cognitive	function	should	be	
a	regular	feature	of	health	assessment	in	the	elderly	in	primary	care,	whether	carried	out	by	the	
family	physician	or	a	team	of	health	professionals	as	part	of	a	comprehensive	geriatric	assessment	
in	community	centres.	Cognitive	assessment	is	even	more	important	in	the	hospital	setting,	as	
the	majority	of	patients	are	elderly,	especially	in	the	medical	wards.	Management	of	multiple	
morbidities	must	take	into	account	the	presence	or	absence	of	cognitive	impairment	to	be	
comprehensive.
Since	assessment	takes	time,	and	doctors	have	limited	time	in	hospitals	as	well	as	in	clinics,	the	
setting	up	of	assessment	teams	by	trained	healthcare	workers	would	be	a	solution,	so	that	doctor	
consultation	time	is	maximised	to	enable	investigations	and	care	plans	to	be	formulated	based	on	
the	report	of	assessment	forms.	Such	a	system	has	been	in	practice	for	primary	care	geriatricians’	
practices	in	the	community	in	the	United	States.
8.3 Care and support for patients and their caregivers
Management	of	the	disease	includes	optimizing	physical	health	and	cognition	through	lifestyle	
modification	and	cognitive	exercises;	detecting	and	treating	behavioural	and	psychological	
symptoms	of	dementia	(BPSD);	providing	information	and	long	term	support	to	caregivers.	The	
use	of	cholinesterase	inhibitors	and/or	other	psychotropic	drugs	may	be	indicated,	but	should	
not	be	regarded	as	the	mainstay	of	treatment.	Other	than	pharmacological	intervention,	other	
modalities	should	include	personal,	cognitive	and	social	rehabilitation.	Empowerment	of	formal	and	
informal	caregivers	through	education,	social	support	and	counselling	is	needed	to	enhance	their	
interactions	with	people	with	dementia,	so	that	excess	disability	is	kept	to	a	minimum	and	quality	of	
life	is	maximised	(Sabat,	2009).
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Dementia	care	would	best	be	delivered	by	a	multidisciplinary	team	in	the	primary	care	
setting,	where	continuity	of	care	is	possible,	supported	by	psycho-geriatricians	and	geriatricians	
in	secondary	or	tertiary	care	settings.	In	this	regard	the	primary	care	setting	in	Hong	Kong	is	not	
supportive	of	elderly	people	with	dementia,	who	often	have	multi-morbidities,	in	that	few	clinics	
have	multi-disciplinary	teams	to	carry	out	detailed	assessments.	Even	in	hospital	settings,	other	
than	patients	under	geriatric	teams,	those	not	under	their	care	may	not	receive	optimal	care.	
In	1999-2000,	Dementia	Day	Care	 in	the	community	as	well	as	Dementia	Care	units	 in	
institutional	care	homes	for	the	elderly	were	piloted	in	the	subvented	sector	as	a	result	of	a	
government	commissioned	consultancy.	One	centre	was	established	by	the	Hong	Kong	Jockey	Club	
Charities	Trust	to	run	on	a	self-sustaining	basis.	The	latter	is	now	entirely	self-sustaining,	showing	that	
this	model	of	care	is	feasible	other	than	government	subvention.	Day	care	programmes	have	been	
shown	to	reduce	BPSD,	caregiver	stress,	and	the	rate	of	functional	decline.	The	use	of	telemedicine	
may	also	have	a	role	in	the	delivery	of	group	cognitive	training	programmes	in	such	centres,	by	a	
professional	in	a	remote	site	(Poon	et al.,	2005).	A	recent	study	in	Hong	Kong	showed	that	cognitive	
impairment,	including	dementia,	is	one	of	the	main	factors	predisposing	to	admission	to	long	term	
institutional	care	(Woo	et al.,	2000).	Improved	support	at	the	community	level	may	delay	admission,	
as	suggested	by	a	past	survey	(Chiu,	unpublished	data).	Studies	in	Finland	(Eloniemi-Sulkava	et al.,	
2001)	and	the	United	States	(Gaugler	et al.,	2005)	also	found	that	offering	community-based	support	
delayed	admission	into	institutional	care.	Demand	for	such	services	is	likely	to	increase	as	a	result	of	
the	impact	of	population	ageing.	
Informal	caregivers	would	need	to	be	an	integral	part	of	care,	however,	the	oldest	old	support	
ratio	has	been	decreasing	in	other	countries	as	well	as	in	Hong	Kong	(Chau	et al.,	2007;	Robine	
et al.,	2007).	A	recent	Hong	Kong	survey	has	shown	that	primary	informal	caregivers	have	worse	
health,	more	doctor	visits,	anxiety	and	depression,	and	weight	loss	compared	with	non-caregivers,	
and	that	all	domains	of	health-related	quality	of	life	were	adversely	affected.	Poorer	physical	and	
psychological	outcomes	were	correlated	with	caregiver	burden	as	measured	by	the	Zarit	Burden	
Scale	(Ho	et al.,	2009).	A	telephone	survey	has	also	found	that	patients	with	dementia	who	get	lost	
in	the	community	put	a	considerable	psychological	strain	on	their	caregivers	(Kwok	et al.,	2010).	
Support	for	caregivers	of	dementia	patients	would	need	to	be	improved,	to	include	both	practical	
as	well	as	psychological	support.	These	may	include	caregiver	education	covering	communication	
and	caring	skills	for	dementia	patients,	and	the	application	of	principles	of	bereavement	used	in	
palliative	care,	since	there	are	similarities	in	the	gradual	loss	of	personhood	of	the	family	member	
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such	that	the	caregiver	may	be	treated	as	a	stranger.	There	is	evidence	that	enhanced	counselling	
and	support	treatment	may	reduce	caregiver’s	depression	(Mittelman	et al.,	2004).	Collaborative	
care	packages	including	education	on	communication	skills,	caregiver	coping	skills,	legal	and	
financial	advice,	patient	exercise	guidelines,	and	caregiver	guide	may	also	improve	quality	of	care	
and	behavioural	and	psychological	symptoms	of	dementia	for	both	people	with	dementia	and	their	
caregivers	(Callahan	et al.,	2006).	Easily	accessible	day	and	respite	care	would	also	be	important.
8.4 Long term institutional care
In	the	latter	stages	of	dementia,	when	the	patient	becomes	immobile,	cannot	swallow,	and	
is	doubly	incontinent,	institutional	care	may	not	be	avoided.	Cognitive	impairment,	including	
dementia,	is	one	of	the	major	factors	influencing	caregivers	to	opt	for	the	choice	of	institutional	
care	(Chau	and	Kwok	et al.,	2010).	There	are	issues	of	quality	of	care,	autonomy	and	dignity	that	
need	to	be	addressed.	Intermittent	reports	in	the	media	in	the	past	two	decades	have	highlighted	
undesirable	practices	amounting	to	abuse.	Quality	of	care	depends	to	a	large	extent	on	adequate	
staff	numbers	(Woo	et al.,	2005).	The	number	of	staff	required	for	an	institution	depends	on	the	
dependency	level	of	the	residents,	and	the	number	required	for	an	acceptable	quality	of	care	
depending	on	case	mix	can	be	estimated	in	a	simple	way	(Woo	and	Chau,	2009).	Using	this	method,	
staff	numbers	in	many	institutions,	particularly	privately	run	ones,	are	not	sufficient.	It	is	recognized	
that	there	is	a	tension	between	quality	and	affordability,	and	this	is	unlikely	to	be	resolved	until	the	
financing	of	long	term	care	is	addressed.
8.5 End of life care
There	is	a	lack	of	awareness	that	dementia	is	a	terminal	illness,	so	that	many	people	with	
advanced	dementia	do	not	receive	palliative	care.	A	study	in	the	nursing	home	setting	in	the	United	
States	showed	that	compared	to	residents	with	cancer,	those	with	dementia	tend	to	have	more	non-
palliative	interventions	(5%	versus	25%	tube	fed),	have	inadequate	symptom	treatment,	and	fewer	
have	advanced	care	planning	(Mitchell	et al.,	2004).	The	6-month	mortality	is	25%	and	18-month	
mortality	is	55%	in	a	recent	survey	of	nursing	home	residents	with	advanced	dementia	(Mitchell	et 
al.,	2009).	These	figures	are	comparable	to	those	for	more	aggressive	cancers.	Pneumonia,	febrile	
episodes	and	eating	problems	were	common,	as	were	distressing	symptoms	of	dyspnea	and	pain.	
In	spite	of	the	terminal	nature	of	the	disease,	burdensome	interventions	such	as	hospitalisation,	
emergency	room	visits,	parenteral	therapy	and	tube	feeding	occurred	in	41%	of	such	cases.	
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A	survey	in	a	non-acute	hospital	in	Hong	Kong	revealed	similar	practices	(Lee	and	Woo,	2008).	
During	a	3-month	period,	28	patients	died	of	end-stage	dementia,	with	a	mean	age	of	88	years.	
About	82%	were	from	institutional	care.	Their	acute	and	convalescence	hospital	stays	lasted	for	
an	average	of	9.3	and	35.9	days	respectively.	The	mean	waiting	time	in	accident	and	emergency	
department	before	admission	was	140	minutes.	During	their	last	hospitalisation	(acute	and	
convalescent),	a	mean	of	44	laboratory	specimens	were	collected	and	4.2	imaging	tests	were	
performed.	During	their	last	stay	in	the	convalescence	hospital,	the	end-stage	dementia	patients	
were	kept	nil	by	mouth	for	a	mean	of	3.3	days,	were	put	on	intravenous	/	subcutaneous	fluids	
for	11.4	days	and	had	taken	antibiotics	for	11.5	days.	All	these	patients	were	incontinent	and	
dysphagic,	79%	were	tube-fed	and	57%	were	on	a	urinary	catheter.	The	median	Norton	score	was	
9/20:	75%	suffered	at	least	one	pressure	ulcer	and	7%	had	gangrenous	limbs.	About	20%	had	their	
arms	restrained	to	prevent	them	from	pulling	off	tubes	and	lines.	About	82%	were	mute	and	the	
maximum	AMT	score	among	the	rest	was	only	3.	While	half	of	these	patients	died	of	pneumonia	
and	18%	died	of	bedsore	or	gangrene	sepsis,	dementia	was	never	labelled	as	the	principle	diagnosis	
in	the	record	and	was	labelled	as	a	secondary	diagnosis	in	only	29%.	
It	has	been	pointed	out	that	palliative	and	hospice	care	could	greatly	improve	the	care	of	
patients	with	advanced	dementia	resulting	in	better	quality	of	life	and	greater	caregiver	satisfaction,	
at	the	same	time	reducing	hospitalisation	(Sachs,	2009).	There	is	a	need	to	raise	awareness	and	
improve	the	quality	of	care	for	such	patients.	A	quality	improvement	initiative	for	such	patients	at	
the	end	of	life	has	been	developed	and	evaluated	in	a	non-acute	hospital,	and	integrated	into	part	
of	the	care	plan	(Woo	and	Lo	et al.,	2009).	
8.6 Legal and financial issues
Raising	awareness	of	the	use	of	the	power	of	attorney	for	decisions	regarding	care	plans	as	well	
as	asset	management	is	important,	and	may	help	reduce	physical	and	financial	abuse	of	those	with	
dementia.	Such	services	and	advice	should	be	easily	accessible	and	user	friendly.
The	costs	of	care	for	patients	with	dementia	can	be	considerable,	covering	expensive	drugs	as	
well	as	payment	for	long	term	social	and	medical	care.	It	is	likely	that	the	financing	of	care	for	people	
with	dementia	would	involve	co-payment	in	addition	to	government	provided	resources.	Perhaps	
such	issues	could	be	highlighted	and	debated	so	that	a	realistic	strategy	can	be	formulated.	In	this	
regard,	societal	ageist	attitudes	may	be	uncovered	that	indicate	lower	priorities	be	accorded	to	such	
patients	where	there	are	resource	limitations.
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8.7 Future research and service development
A	research	database	covering	various	aspects	of	dementia	in	Hong	Kong	(such	as	epidemiology,	
pharmacological	treatments,	patients’	and	caregivers’	needs,	different	modes	of	service	delivery	and	
evaluation,	cost	effectiveness)	would	be	useful	so	that	gaps	in	knowledge	could	be	identified.	Such	
information	would	be	necessary	to	enable	the	development	of	a	dementia	strategy	for	Hong	Kong.
The	CADENZA	Project,	a	Jockey	Club	Initiative	for	Seniors,	being	a	collaborative	effort	between	
the	Hong	Kong	Jockey	Club	Charities	Trust,	the	Faculty	of	Social	Sciences	of	The	University	of	Hong	
Kong,	and	the	Faculty	of	Medicine	of	The	Chinese	University	of	Hong	Kong,	has	been	addressing	
some	of	the	areas	listed	above.	Supported	by	the	Project,	a	public	survey	revealed	poor	knowledge	
relating	to	the	care	of	people	with	dementia	(Chau	and	Mak	et al.,	2010).	The	Project	also	supported	
training	of	professionals	and	the	lay	public	regarding	elderly	issues	including	dementia	care	
(CADENZA,	2009a),	supported	a	quality	improvement	initiative	for	end	of	life	care	in	a	non-acute	
hospital	(Woo	and	Lo	et al.,	2009),	supported	a	study	on	the	needs	of	caregivers	and	elderly	people	
who	require	care	with	an	emphasis	on	dementia	(Chau	and	Kwok	et al.,	2010)	and	initiated	an	
integrated	social-medical	care	model	in	the	community	where	those	with	cognitive	impairment	
may	receive	various	services	(CADENZA,	2009b).
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Almost	91,000	people	aged	60	and	above	had	dementia	in	Hong	Kong	in	2006,	and	over	
105,000	in	2010.	With	the	ageing	population,	the	number	of	cases	of	dementia	is	expected	to	
increase	to	about	273,000	by	2036.	Dementia	contributes	significantly	to	disability	and	about	
286,000	years	of	healthy	life	were	lost	due	to	dementia	in	Hong	Kong	in	2006.	The	majority	of	the	
burden	caused	by	dementia	was	due	to	disability	rather	than	premature	death,	with	disability	
accounting	for	99.3%	of	the	total	disease	burden.	Costs	for	dementia	are	enormous,	and	institutional	
care	and	informal	care	constitute	the	major	components	for	financial	costs	of	dementia.	By	2036,	
the	annual	costs	of	institutional	care	would	increase	to	around	HK$	4,212	million,	whilst	the	annual	
costs	of	informal	care	were	projected	to	be	HK$	27,004	million.	With	the	publication	of	this	report	
highlighting	the	impact	of	dementia	on	an	ageing	population,	it	is	hoped	that	public	awareness	
could	be	raised	and	a	strategy	developed	to	improve	the	quality	of	life	and	quality	of	care	for	those	
with	dementia.	Therefore,	formulation	of	a	dementia	care	strategy	as	part	of	a	care	of	the	elderly	
strategy	would	be	important	for	Hong	Kong,	in	view	of	the	magnitude	of	the	dementia	burden.
Conclusion
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